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ABSTRACT 
 
FUNCTIONAL AND STRUCTURAL STUDIES OF CYTOCHROMES P450 BY 
RESONANCE RAMAN SPECTROSCOPY 
 
By Yilin Liu, B.Sc. 
Marquette University 
Cytochrome P450 is a broad class of heme monooxygenase enzymes which 
catalyze various oxidative transformations. There are two main kinds of mammalian 
P450s: steroidogenic and drug metabolizing P450s. The first project involves a 
steroidogenic P450, CYP17A1, occupying a central role in the biosynthesis of steroid 
hormones. It catalyzes hydroxylation reaction on pregnenolone and progesterone, 
generating 17OH-pregnenolone and 17OH-progesterone, presumably utilizing a 
“Compound I” species. However, these hydroxylated products can be further processed 
in a second oxidative cycle to cleave the C17–C20 bond to form dehydroepiandrosterone 
or androstenedione, respectively, a crucial step in androgen production. Interestingly, it is 
well known that cytochrome b5 is a key regulator of androgen synthesis, by a mechanism 
that is still not well understood. As the enzymes involved here are both membrane-bound, 
resonance Raman (rR) studies are performed on unique nanodisc-based dyads to 
investigate their interaction, including characterization of their ferric state and unstable 
dioxygen intermediates, the essential results supporting an electron transfer role of cyt b5. 
The second project is focused on a fusion enzyme called P450BM3, which possesses a 
covalently linked cytochrome P450 reductase. This fusion enzyme is clearly a good target 
for biotechnologically application. In the present work, rR studies focus on several 
biotechnologically important mutants of P450BM3, which have altered substrate 
selectivity, allowing metabolism of the human proton pump inhibitor, omeprazole, 
producing metabolites that precisely match those generated by human CYP2C19, thereby 
providing an inexpensive source of these precious materials that are needed for drug 
metabolism studies. Specifically, it is shown that binding of omeprazole to these BM3 
mutants leads to differing degrees of high spin state conversion of the heme iron. 
Furthermore, the ferrous CO adduct were acquired to interrogate the effect of substrate 
binding on the distal pocket architecture. The third project involves the 
biotechnologically important peroxygenases. Specifically, rR studies are applied to 
CYP152L1 and CYP152L2 enzymes, which are able to convert fatty acids into 
industrially valuable terminal alkenes without requiring a complex reductase system. 
Herein, using chemical strategies to trap and isolate key reaction intermediates, rR 
spectroscopy is being employed to probe their structure and reactivity.  
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Chapter 1: General Introduction 
1.1 Introduction of heme proteins 
Heme enzymes are one of the most important classes of proteins that perform a 
variety of functions throughout the biosphegxre, such as oxygen storage and transfer, 
electron transfer and catalyzing difficult chemical reactions such as hydroxylation of 
organic substrates. One or more heme cofactors1 are recruited into enzyme active sites to 
accomplish these diverse functions. 
Iron-porphyrin complex, known as heme cofactor, plays a key role in biological 
process and metabolic pathways. So far, several different types of natural heme prosthetic 
groups are identified, such as heme a, heme b, heme c, heme d, and siroheme.2 While 
among these groups, b type heme is the most abundant and widely encountered. The 
molecular structure is shown in Figure 1.1.1, four methyl groups are located at the 1-, 3-, 
5-, and 8- position, two vinly groups are at the 2-, 4- position and two propionate groups 
are at the 6-, 7- positions. The upper side of porphyrin is hydrophobic which usually 
interact with the hydrophobic amino acid residues, while the lower side is more polar 
with the propionate groups attached, preferring to interact with the polar amino acids 
residues, such as glutamate and aspartate.  Thus, heme b is bound in the heme pocket via 
the non-covalent interactions with amino acid residues as well as by establishing 
coordination between heme iron and an endogenous axial ligand, such as histidine in 
myoglobin; relevant to this work, the axial ligand is cysteine in cytochrome P450.3  
2 
 
The functions of heme b type proteins are various. Hemoglobin is the most 
common O2 transport protein in nature and myoglobin is the O2 storage sites in muscle 
cells,4 cytochrome b5 is known to be involved in the electron transfer of oxidation 
reactions in biological tissues,5 some heme-based sensor proteins such as FixL,6 CooA,7 
and sGC,8 are functioned to sense O2, CO and NO molecules to initiate some chemistry 
requirement in biological system, and cytochrome P450 and some peroxidases are used to 
oxidize a wide range of substrates by employing O2 and H2O2, respectively.
9
  Thus, study 
of these enzyme structures and catalytic mechanisms becomes very significant. 
Resonance Raman spectroscopy is one of the most effective techniques to probe iron 
electronic structure, heme peripheral environment, ligand binding properties as well as 
characterization of intermediates in catalytic cycles.10  
 
Figure 1.1.1 Molecular structure of heme b. 
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1.1.1 Globins 
The globins are an extensive family of proteins which all have very similar 
structures, are commonly a three-dimensional folding of a few  helices to form a globin 
fold which protects the bound heme group and allowing the oxygen binding and 
transport.11 Myoglobin and hemoglobin are two main classes which are most well 
studied. They are the first proteins for which crystal structures were determined by X-ray 
crystallography.12 Myoglobin is very abundant in muscles in varieties of organisms, 
serving as oxygen storage. It is a single peptide chain containing 153 amino acids, which 
consists of eight helices connected by turns, with one bound heme (Figure 1.1.2).13 
While hemoglobin carries oxygen from the lungs to peripheral tissues and returns carbon 
dioxide back to lungs, it is a much larger protein than myoglobin, being a tetramer 
consisting of two  chains and two  chains. It contains four heme prosthetic groups, 
each one associated with one polypeptide chain (Figure 1.1.3).14 Both myoglobin and 
hemoglobin bind oxygen at the iron atom in heme. In the deoxy form, ferrous heme iron 
is coordinated by the imidazole part of histidine in proximal side (the fifth ligand), while 
the sixth ligand is unoccupied, this position serving for binding oxygen. When oxygen 
binds, the electronic structure of iron ion is rearranged, which gives the bright red color 
of oxygen-rich blood. 
4 
 
 
Figure 1.1.2 A ribbon diagram of the sperm whale Myoglobin. Eight  helices are 
labeled A through H and heme group were shown in ball and sticks.13 
 
Figure 1.1.3 Quaternary structure of hemoglobin. (A) Ribbon diagram (B) A space 
filling model.14  
Though these two proteins adopt nearly identical structure for oxygen binding, 
hemoglobin obviously has a much higher efficiency. Instead of exhibiting a simple 
hyperbolic curve like myoglobin, it exhibits a distinct sigmoid curve which means it 
binds oxygen cooperatively (Figure 1.1.4). This interesting process initiates from the 
binding of one or two molecules of oxygen, which results in a structural change of the 
whole protein, enhancing the oxygen affinity in the unligated subunits. Because of this 
5 
 
allosteric effect, hemoglobin is more effective in transporting oxygen concentration in 
lungs and tissues, loading up with oxygen in the oxygen-rich lungs and more effectively 
release oxygen in the oxygen-poor tissues, where the reverse allosteric effect to this place 
after one or two molecules of oxygen were dissociated.15 
 
 
Figure 1.1.4 Oxygen binding by myoglobin (blue curve) and hemoglobin (green “S” 
shape curve).15  
1.1.2 Electron transfer hemeproteins 
Redox reactions occur in many biological processes, such as photosynthesis and 
respiration, which are two necessary processes that maintain life. Nature recruited 
transition metals to overcome the kinetic barrier of these reactions. Cytochrome c and 
cytochrome b5 are two representative proteins involved in a large number of biological 
electron transfer process.16  
Cytochrome c is an essential component in electron transport chain which is 
found in inner membrane of mitochondria, where it participates in oxidation and 
6 
 
reduction reactions to produce the energy currency, ATP.  It is a small protein containing 
around 100-120 amino acids with only 12kDa molecular weight.17 As shown in Figure 
1.1.5, there are different types of heme found in cytochromes and cytochrome c contains 
the c-type heme, with the axial ligands of histidine and methionine to covalently link to 
the protein peptide chain. Another electron transport hemeprotein, cytochrome b5, 
contains a bis-histidine ligated b-type heme and is found in bacteria, plants and animals. 
They are membrane bound in mitochondria and microsome, while soluble in bacteria. 
They can exhibit the redox potential span of ~400 mV and interact with their redox 
partners primarily by electrostatic forces. Of interest in this study, cytochrome b5 is 
involved in a fast input of the second electron to P450 monooxygenase enzyme, which is 
critical for the oxygen activation.5  
 
Figure 1.1.5 Schematic of various types of heme.18  
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1.1.3 Signaling hemeproteins 
There is a minor class of hemeproteins called sensor proteins, which can sense the 
presence of small diatomic ligands such as oxygen, carbon monoxide and nitric oxide, 
thereby responding to fluctuations in the levels, serving to regulate physiological 
functions, adapting the changes in varieties of organism. All these proteins are composed 
of a heme-containing domain and a coupled transmitter. Upon the binding of the diatomic 
small molecules, the conformational of heme binding domain is transmitted to its coupled 
functional domain (neighbored transmitter region) where it can modulates the signal 
transduction to fulfil its physiological role. 
Some well characterized signaling proteins are the bacterial O2 sensor, FixL,
19 the 
CO sensor, CooA20 and the NO sensors HNOX21 and soluble guanylate cyclase (sGC). 
Taking the NO sensor sGC for an example, sGC is a heterodimeric enzyme (one  
subunit and one heme-containing  subunit), which contains a five-coordinated b-type 
heme with the heme proximal coordination being provided by the protein amino acid 
sidechain of a histidine residue in its nature ferrous form.22 Resonance Raman studies 
have shown that this Fe-Nhis bond is the weakest in all hemeproteins, having a very low 
frequency of iron histidine stretching mode (204 cm-1).23 Upon binding of NO molecule 
in distal pocket, the proximal iron histidine bond cleavage leads to the protein 
conformational change which further increases the sGC activity in the catalytic domain, 
converting GTP to intercellular messenger cGMP (Figure 1.1.6). Following Le Chatlier’s 
principle, sGC can spontaneously release NO molecules when NO levels drops to a 
clinical value, thereby down regulating cGMP.24 
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Figure 1.1.6 sGC in the NO signaling pathway.25 
The discovery of heme sensor proteins has been increasing rapidly, with insights 
into this class of protein mechanism being developed by using varies of biophysical 
methods and crystallography, providing a better understanding how these heme binding 
domain in turn controls the signal transduction domains. 
 
1.1.4 Catalytic hemeproteins (cytochromes and peroxidases) 
There are several broad classes of hemeproteins which serve to catalyze oxidation 
reactions, one of which is the Cytochromes P450, which use O2 and two electrons and 
two protons to oxygenate relatively inert substrates, and the other is peroxidases, 
monooxygnease known using H2O2 for substrate oxidation. As shown in Figure 1.1.7, 
heme oxygenase use NAD(P)H –dependent reductase system and O2 bound intermediate 
to produce the active oxidant called compound I. While the peroxidase can directly 
interact with H2O2 to produce compound 0 which then rapidly converts to compound I. 
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Avoiding any need for partner reductase in the H2O2 activation pathway is a big 
advantage, thus attracting a huge potential interest for biotechnological purpose. Though 
peroxidases can operate without electron donor protein, H2O2 is a major source of 
reactive oxygen species via Fenton chemistry. Since the release of toxic hydroxyl radicals 
is highly destructive to the enzyme active site, peroxidases facilitate heterolytic O-O 
cleavage to avoid radical formation. Since Cytochrome P450s will be discussed later in a 
much detail in the next sections, emphasis will be placed on the H2O2 driven peroxidases. 
 
 
 
Figure 1.1.7 Oxygen and Hydrogen peroxide activation pathway.9 
Peroxide enzymes use hydrogen peroxide to oxidize biological molecules 
including a wide variety of substrates, playing multiple physiological roles, they have 
been studied extensively owing to their ease of preparation of large amount of purified 
enzymes. There are two well defined superfamilies of peroxidases: one belongs plant 
peroxidase superfamily which contains enzymes from plant, fungal and bacteria, while 
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the other superfamily is mammalian peroxidases such as lactoperoxidase and 
prostaglandin H synthase. Among all different kinds of peroxidases, horseradish 
peroxidase (HRP) was first to be thoroughly studied over the past century.  
Horseradish peroxidase is an important heme-containing enzyme which exhibits 
multiple physiological roles, including metabolism of 3-acetic acid, suberin formation 
and cross-linking of cell wall polymers.26 It is a single polypeptide chain of 308 amino 
acid residues, with a heme b cofactor bound via a histidine axial ligand. As shown in 
Figure 1.1.8, there is a strong hydrogen bonding interaction between proximal histidine 
170 and aspartic acid 247 residue, giving the axial ligand more imidazolate character, 
lowering Fe3+/2+ redox potential. The distal pocket remains unoccupied by water and 
ready for H2O2 turnover and substrate oxidation.  
 
 
Figure 1.1.8 Horseradish peroxidase heme structure and key amino acids in the proximal 
site.27 
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Treatment of HRP with hydrogen peroxide yields a relatively stable compound I 
species (i.e.; a porphyrin pi cation radical) with a distinct green color; then is formed by 
removal of one electron from iron and a second from the porphyrin ring, with peroxide 
being reduced to water. Then one electron oxidation of a substrate molecule, reduces the 
porphyrin pi radical to generate compound II (a ferryl heme). Finally, compound II is 
reduced to the ferric state by a one electron, one-proton transfer process. This whole 
catalytic process is shown in Figure 1.1.9. 
 
Figure 1.1.9 The reaction cycle of HRP (where AH2 and AH represent a reducing 
substrate and its radical product); Roman numerals indicate iron oxidation state.28  
 
12 
 
1.2 Cytochrome P450 
1.2.1 General Introduction 
Cytochromes P450 is one of the most remarkable enzyme families in the 
biological kingdom, being found in diverse organisms, such as bacteria, yeast, plants, 
fungi and mammals. Cytochrome P450 was first identified in liver microsome by 
Kingenberg29 and Garfinkel30 in 1958. The name of P450 was given to it owing to the 
fact that its carbon monoxide adduct exhibits a maximum Soret band at 450 nm, as shown 
in Figure 1.2.1.  
 
 
Figure 1.2.1 The absorption spectrum of cytochrome P450-CO complex.31 
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So far over 18,000 P450 sequences have been discovered and this number keeps 
increasing.32  The human genome encodes 57 cytochrome P450 proteins, while bacteria 
possess 153 P450 families. In order to keep a record of this enormous information, a 
nomenclature system has been derived based on the degree of protein sequencing 
identity.33 CYP was abbreviated for cytochrome P450 followed by an Arabic number 
representing a family in which the proteins have more than 40% sequence identity. Then 
a letter, indicating the subfamily where proteins share more than 55 % same sequence 
within the subfamily. Finally, an Arabic number at the end denotes the individual gene, 
such as CYP2C8 (Figure 1.2.2). However, some cytochrome P450s are also named based 
on its catalytic function and substrate name; for example, CYP5A1, thromboxane A2 
synthase, was abbreviated to TXAS.34  
 
Figure 1.2.2 Nomenclature basis for P450s and classification. 
Cytochrome P450s are considered as a significant catalyst in biology, playing a 
critical role in oxidizing a wide range of substrates.31 Although the reactions catalyzed by 
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cytochrome P450 are extremely diverse, most of them can be accommodated to the basic 
catalytic reaction below. 
 
P450 can oxidize the organic substrate (RH) by employing the oxygen, to produce 
a mono-oxygenated metabolite (ROH) and a molecule of water. In this reaction, two 
electrons provided by redox proteins are required. Based on electron transport chain, 
three main classes cytochrome P450s are described below. 35, 36. 
Class I type cytochrome P450s usually are found in bacterial and some 
mitochondrial P450s systems, both systems obtaining electrons from a pyridine 
nucleotide (i.e. NADH or NADPH) via a FAD-containing reductase (FdR) and a Fe2S2 
ferredoxin (Fdx). However, there is a main difference between bacteria and eukaryotes 
systems. In bacteria, the reductase, ferredoxin and P450 are all soluble (Figure 1.2.3 A). 
In eukaryotes, ferredoxin is alone soluble, while both the reductase and P450 are 
membrane-associated proteins and can bound to the inner mitochondrial membrane, as 
shown in Figure 1.2.3 B. Examples of Class I type P450 includes P450cam in bacteria. 
 
Figure 1.2.3 Schematic organization of electron transfer in (A) Class I bacterial system 
(B) Class I mitochondrial system. 
15 
 
Class II type cytochrome P450s are involve in mostly microsomal P450 systems. 
In this system, electrons are transported from NADPH to the heme of P450 via NADPH-
Cytochrome P450 reductase (CPR) which contains two prosthetic groups, FAD (Flavin 
adenine dinucleotide) and FMN (Flavin mononucleotide). Both NADPH-Cytochrome 
P450 reductase and P450 are anchored in the membrane. The scheme of electron transfer 
route is shown in Figure 1.2.4. In addition, a minor number of microsome P450s also use 
cytochrome b5. 
 
Figure 1.2.4 Schematic electron transfer route in P450s with NADPH-P450 reductase 
system.37 
Class III type P450s are self-sufficient and usually do not need any extra source of 
electrons. Examples of this type includes P450 BM3, it consists of a single polypeptide 
chain with two different domains, which the heme domain is fused to the reductase 
domain containing an FAD and FMN. This novel type of fusion is defined as a new class 
of discovered P450. 
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1.2.2 Active site structure of Cytochrome P450 
P450s are crucial in many biological processes, they are involved in breaking 
down the xenobiotics in drug metabolism as well as in the biosynthesis of important 
compounds such as steroids, lipids, and vitamins. In order to better understand the 
structure-function relationship, very many studies have been undertaken to explore 
structure function relationships. Owing to the difficulty with purification and 
recombinant expression of membrane-bound P450s, the soluble P450s such as P450cam, 
were most heavily studied at earlier time. 
The P450 enzymes all are composed of a heme b bound through a thiolate axial 
ligand to a single polypeptide chain consisting mainly of -helices and  sheets arranged 
to form a globular protein, with a size of 40~55 kDa. Even though the complicated P450 
enzymes have variable structures, the overall fold and topology are basically same.38 All 
enzymes share a highly reserved core which consists of a four-helix bundle, three parallel 
helices D, L, I and one antiparallel helix E, as shown in Figure 1.2.5. The long I helix 
locates right above the heme prosthetic group and provides important amino acid residues 
to interact with both substrate and molecular oxygen. While the L helix is located as the 
proximal side of heme group to provide the cysteine residue to bind to the heme iron as 
the fifth ligand. Various spectroscopic methods including Resonance Raman 
spectroscopy was used to detect this iron-sulfur bond.39 
Cytochrome P450 shows diverse conformation and marked regio- and stereo- 
selectivity toward different substrates. The non-conserved region, is necessary for this 
substrate binding and recognition.40 Six substrate recognition sites were identified by 
Gotoh which constitute about 16% of the total residues, as shown in Figure 1.2.6. The 
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SRS1 was assigned to the B’ helix region, parts of helices F and G and the F-G loop were 
identified as SRS2 and SRS3. The center position of helix I was ruled as SRS4 which 
contributes key role in substrate binding and reaction mechanism. The N-terminus of 4 
was SRS5 and 2 connecting region which towards to active site in K helix was SRS6. 
All these regions are quite flexible which allows the substrates entering and leaving the 
heme pocket and catalyzing reactions subsequently.41 
 
Figure 1.2.5 Schematic representation of P450cam structure. 
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Figure 1.2.6 The substrate recognition sequence (SRS) regions in a ribbon 
representation.42 
1.2.3 Catalytic Mechanisms of Cytochrome P450 
Owing to the diverse applications of cytochrome P450, there is a wide interest in 
studying these various enzymes, especially the catalytic mechanism. An overall catalytic 
cycle proposed is shown in Figure 1.2.7.43 In the resting state, the heme iron is in the six 
coordinate, low-spin (6cLS) state, with a water molecule occupying the sixth ligand 
position. Upon binding a substrate, water molecule was displaced from distal axial 
position which bring heme iron from low spin state to a five coordinated high spin 
(5cHS) state. Then an electron is passed from NADPH via a redox partner to the heme 
iron, the ferric iron being reduced to the ferrous iron while still in high-spin state. 
Molecular oxygen binds to the heme iron leading to an oxy-P450 species, which is more 
properly formulated as a ferric superoxide species. Then a second electron is transferred 
to the Fe-O-O fragment, forming a ferric peroxo species. Generally, this is followed by a 
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fast protonation from surrounding amino acid residues or water molecule, to become a 
ferric hydroperoxo species. A second protonation at the distal oxygen atom leads O-O 
bond cleavage, with a water molecule leaving and formation of highly reactive species 
compound I. This species hydroxylates the substrate and returns to the resting state after 
product release. 
However, three major abortive reactions can happen in this cycle.44 The oxy-
ferrous enzyme can be auto-oxidized back to its resting state with leaving of a superoxide 
ion. In addition to this auto-oxidation process, a so-called “peroxide shunt” pathway is 
possible by producing H2O2 from hydroperoxide. The last abortive reaction is “oxidase 
shunt”, the compound I can return to the resting state by leaving two molecules water 
without going to oxygenate the substrate. These uncoupling processes may happen when 
the electron or proton delivery is not timely, or the substrate is positioned inappropriately. 
 
Figure 1.2.7. Catalytic cycle of P450.45  
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1.2.3.1 Substrate binding 
The hydrophobic substrate binds in pocket above heme cofactor and the water 
molecule is displaced. This process not only shifts the heme iron from low spin to high 
spin state, but also raises the redox potential from -300 mV to a 100mV more positive, 
such as the case of camphor binding to P450cam.46 The redox potential shift guarantees 
electrons are only transferred to the enzyme in substrate-bound form; i.e., since the 
midpoint potential of reducing equivalent (NADPH) is -320 mV, this balance ensures no 
waste of NAD(P)H and avoids reducing equivalents formation of toxic species such as 
superoxide. Moreover, conditions such as temperature, pH and solvent may also affect 
the low spin and high spin equilibrium as well as the redox potential of heme iron.  
Basically, the interactions of substrate with P450s can be seen in the spectral 
properties of the enzyme. According to the observed UV spectral changes of P450 upon 
binding substrates, P450s can be classified into three catalogues: type I and type II.47 
Specifically, type I substrate can cause the heme iron change from 6cLS to the 5cHS 
state, which can be seen from the UV-vis spectra that the decrease of an 420 nm band and 
an increase at 390 nm depending on the percentage of high-spin state heme iron. 
Compared with type I substrates, type II substrates usually are inhibitors or certain other 
substrates which can directly ligate to the heme iron, forming tightly-bound complexes; 
e.g., N atoms of aromatic and aliphatic amines. The spectrum generally shows a low spin 
iron. 
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1.2.3.2 Oxygen complex 
Oxygen can readily binds to reduced P450 in substrate bound form, forming the 
oxy complex which is usually depicted as the ferric superoxide complex, as mentioned 
above. The gross structure is very similar with the oxygen carrier such as hemoglobin and 
myoglobin. According to the X-ray crystal structure of P450cam ferrous dioxygen 
adduct, as shown in Figure 1.2.8, bimolecular oxygen binds to the heme iron in an end-on 
form with the angle of Fe-O-O 132°, the distance between iron and the nearest O atom is 
1.8Å. The iron is slightly out of plane while the heme becomes flatter. The Asp251 and 
Thr252 residues play critical roles, serving as H-bond donor and proton transfer agents.48 
 
Figure 1.2.8 Stereoview of the camphor complex of ferrous dioxygen-bound P450cam. 
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1.2.3.3 Peroxo and Hydroperoxo intermediate 
With the second electron transferred to the heme iron, the ferric superoxide 
species is reduced to the ferric peroxide complex in the catalytic cycle. This species is 
quickly protonated to form a hydroperoxo intermediate. Both of these two intermediates 
are in low spin state. Owing to rapid delivery of a second proton and facile O-O bond 
cleavage to generate compound I, isolation and stabilization of these is extremely 
difficult. As will be seen, cryogenic radiolysis is one of the methods that can be used to 
trap those intermediates. It was demonstrated that the peroxo species was stable enough 
to be characterized in the frozen solution at 77K, and thus the hydroperoxo intermediate 
could be obtained by annealing to elevated temperature.49 By using this method, both 
intermediates were identified by spectroscopic methods such as UV-vis, EPR and 
resonance Raman spectroscopy.50  
1.2.3.4 Compound I 
The protonation of ferric hydroperoxo species and the heterolytic cleavage of the 
O-O bond lead to the formation of Compound I and release of a molecule of water. 
Compound I has been characterized as an iron (IV) oxo species, with a π cation radical 
located on the porphyrin macrocycle. In the presence of substrate, compound I rapidly 
reacts and is difficult to capture. Over the past decades, different models and methods 
were tried to characterize compound I with limited success.51 However, recently 
compound I was captured and detected in CYP119 by reacting with m-chloroperbenzoic 
acid, thus enable spectroscopic methods to characterize it. As expected, Mossbauer and 
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EPR spectra indicated compound I is a Fe (IV) =O species with the ferry iron spin (S=1) 
antiferromagnetically, porphyrin radical spin equals ½ to yield the total spin state ½.52 
1.2.3.5 Hydroxylation of substrate 
Hydroxylation of substrate is the last step in the catalytic cycle, where Compound 
I inserts an O atom into the hydrophobic substrate and returns back to the resting state by 
releasing the product. It is generally accepted that the mechanism for substrate 
hydroxylation is a radical rebound process.53 Compound I abstracts a hydrogen atom 
from the substrate while leaving a carbon radical, and this radical can rebound to the 
species with a recombination process to give the hydroxylation product. 
 
1.3 Resonance Raman Spectroscopy 
1.3.1 The Raman Effect 
Resonance Raman spectroscopy is a powerful method to probe the active site 
structure of heme proteins and other metalloproteins because the vibrational frequencies 
and intensities are very sensitive to the structure and the protein environment. Although 
both IR and Raman spectroscopy can be employed to investigate molecular vibration 
modes, Raman is best to be used in the symmetric and polar molecules. In addition, IR 
has difficulty working with aqueous solution owing to the intense absorption of H2O 
throughout the IR region which make the measurement inconvenient since most proteins 
are measured in aqueous solution. However, Raman spectroscopy does not suffer this 
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limitation because water is a poor Raman scatterer.10 The mechanism for Raman 
spectroscopy can be explained via the energy level scheme as shown in Figure 1.3.1. 
When a monochromatic light from a laser source with frequency impinges on the 
sample, it can interact with molecules and lead to the laser energies either unchanged or 
being shifted up or down. In general, most of light will be scattered as the same energy 
with the incident light, which is called Rayleigh scattering, giving a very intense peak in 
the spectrum. 
However, some of the incident light is scattered at lower energy if the molecule 
undergoes a transition from the ground vibrational state (0) to an excited vibrational 
state (1), which is referred as Stokes Raman Scattering. Occasionally a photon 
encounters a molecule that is vibrational excited (e.g., in the 1 state) and the scattering 
process leaves the molecule in 0, i.e., free photon gains energy from the molecule. This 
is called anti-Stokes scattering. The intensities of Stokes scattering is stronger than the 
anti-Stokes region, because few molecules will occupy an excited vibrational state, 
according to the Maxwell-Bolziman distribution law. The line thickness is roughly 
proportional to the intensity strength from different scattering in Figure 1.3.1.  Thus, the 
scattering intensities of Strokes line is reported as a function of frequencies in Raman 
spectroscopy. 
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Figure 1.3.1 Energy level scheme of vibrational Raman scattering process. 
Resonance Raman spectroscopy can selectively enhance the vibrational modes by 
using the laser excitation line which is close to the electronic absorption of the 
chromophoric heme prosthetic group, which is necessary for biological macromolecules 
which contain thousands of atoms and vibrational frequencies. A detailed illustration of 
enhanced resonance Raman spectroscopy is shown in Figure 1.3.2, trace A exhibits the 
structure of a complicated molecule tris-phenanthroline Fe (II) and trace B shows the 
corresponding absorption spectra with a strong MLCT transition appearing at 514.5 nm. 
As seen in trace C, different excitation laser lines were employed to characterize the 
samples which contain a non-enhanced internal standard (SO4
2-). When the 647.1nm 
excitation line is used (far from the MLCT maximum), the Raman spectra is dominated 
by the sulfate ion with (S-O) occurring at 981 cm-1. However, as the excitation line 
approaches to the MLCT maximum bands, the vibrational modes for tris-phenanthroline 
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Fe (II) are greatly enhanced, even though its concentration is 1000 times less than the 
internal standard sulfate ion.54 
 
Figure 1.3.2 (A) Structure of tris-phenanthroline Fe(II); (B) Absorption spectroscopy of 
tris-phenanthroline Fe(II); (C) Resonance Raman spectroscopy with different excitation 
laser lines. 
1.3.2 Resonance Raman Spectroscopy applied in heme proteins  
Resonance Raman spectroscopy is a powerful method to study the structure and 
function of metalloproteins especially heme enzymes. By adjusting the wavelength of the 
exciting laser line close to that of allowed electronic transition in a molecule, certain 
vibrational modes can be selectively enhanced. Such an advantage provides the 
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possibility to collect good quality data even though using a small amount of sample. For 
example, hemoglobin is a large molecule with a molecular weight of 64 kDa, and its 
visible spectra is shown in Figure 1.3.3.55 Generally, the vibrational modes of the peptide 
chain gains much weaker scattering and are not detectable, however, if a deep UV laser is 
applied, at 280 nm, it will selectively enhance vibrational modes from the surrounding 
amino acid residues in hemoglobin such as tyrosine, histidine, tryptophan and 
phenylalanine, which have electronic absorption in this region.56 Alternatively, if the 
laser line is near the Soret band (most intense π-π* transition), only the heme bands can 
be seen. Thus resonance Raman spectroscopy allows us to observe the vibrational modes 
only in the active site.  
 
Figure 1.3.3 Electronic absorption spectroscopy of human hemoglobin. 
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1.4 Resonance Raman studies of Iron-axial ligated P450 Adducts 
1.4.1 Metal-ligand interactions in Hemeproteins 
The heme prosthetic group in heme enzymes is capable of binding the 
exogenouos diatomic ligands XY, such as CO, NO and O2. The Fe-XY adduct can 
interact with the surrounding amino acid residues, affecting the bond strength of the Fe-X 
and X-Y linkage, as reflected in changes of the vibrational modes by resonance Raman 
spectroscopy. Binding the exogenous ligands can activate or inhibit key biological 
processes. For example, hemoglobin can transport O2 by ligation of molecular oxygen 
with heme iron, whereas binding with CO can prevent O2 binding. The general geometry 
of Fe-X-Y can be linear or bent depending on the electronic configurations and bond 
properties of XY ligands. As shown in Table 1.4.1, The CO ligand has an empty π* 
orbitals and thus form a linear adduct which dπ- π* overlaps in a perpendicular directions. 
However, NO and O2 have one and two electrons on π* orbitals, respectively, and thus 
form the bent geometry, owing to a π antibonding interactions. However, the geometry 
can be disturbed by the steric hindrance in the protein environment.57 
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Table 1.4.1. Electronic configuration and bond properties of diatomic ligands. 
 
 
The binding interactions between iron and the ligand can be classified into two 
kinds; σ-bonding and π-bonding, as shown in Figure 1.4.1. σ-bonding is formed by the 
interaction between the metal dz
2 with either the ligand lone pair electrons or the π* 
orbital of ligand. Because the energies of the dz
2 and π* orbitals are very close, the 
strength of bond is relatively strong. In the case of CO, NO and O2, the energy of π* 
orbitals decrease from CO to NO to O2, leading to increased bond strength. 
The π-bonding is formed between the metal dπ (dxz and dyz orbitals) and the ligand 
π* orbital. This interaction involves the electron shift from iron to the ligand in the dπ- π* 
system and a back donation to the iron in the σ system, thus leading to a strengthened M-
X bond and a weakened X-Y bond. In addition, the axial ligand of heme protein, usually 
histidine or cysteine, can also affect these bond strengths. A σ competition between the 
trans axial ligand and the exogenous ligand can weaken the Fe-X bond.  
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Figure 1.4.1 Representation of σ- and π-bonding interactions between metal ion and 
diatomic ligand.58  
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1.4.2 Resonance Raman spectroscopy to probe CO, NO and O2 P450 complex and 
unstable fleeting intermediates in the catalytic cycle. 
1.4.2.1 Ferrous CO P450 complex 
CO can bind to the high spin ferrous heme iron to produce a low spin heme in 
P450s, giving a maximal absorption band around 450 nm. As mentioned earlier, the Fe-
CO fragment is expected to be linear. However, in some cases, it can cause a slight bent 
geometry due to the steric constriction in the protein environment.  
Since resonance Raman is an effective method to detect the subtle environmental 
alternations, vibrational modes of Fe-CO fragment have been identified by isotopic 
substitution of the bound CO. Both the modes of Fe-C and C-O can be enhanced in 
resonance with the heme Soret absorption band, i.e, using the 441.6 nm excitation line. 
In Figure 1.4.2, it can be seen that a band occurs at 481 cm-1 shifted to 478 cm-1 
upon the isotope substitution from 12C18O to 13C16O in substrate-free P450cam, and upon 
substitution by 13C16O, it shifted to 473 cm-1. Thus this feature occurs at 481 cm-1 was 
first assigned as (Fe-CO) stretching mode.59 
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Figure 1.4.2. Effect of the substitution by isotope-labeled CO on the substrate-free form 
of P450cam. 
The Fe-C-O bending vibration was assigned at 558 cm-1 owing to the significant 
shift (14 cm-1) upon 13C16O substitution, giving only a -3 cm-1 on 12C18O substitution. The 
substrate binding on the P450cam caused a shift of Fe-CO stretching mode from 481cm-1 
to 464 cm-1, which indicates the bound substrate can interact with Fe-CO fragment, 
distorting the active site structure.  
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1.4.2.2 NO P450 complex  
Nitric Oxide is able to bind with heme iron both in ferric and ferrous states. The 
geometry of Fe (III)NO is expected to be linear for compounds without distal steric 
effects, whereas it can become slight bent in the presence of substrates, in a manner 
similar to Fe (II)CO since they are isoelectronic. However, one main difference between 
these two adducts is that the electron in the NO π* orbital is delocalized over the Fe dπ 
and NO π* orbitals which lead to a strengthened NO bond owing to an increased bond 
order. This can also be detected in the high frequency region of rR spectra, where a 
feature occuring at 1877 cm-1 assigned as  (NO) was observed.60 Limited studies have 
been conducted on Fe(III)NO, owing to laser-induced photo reactivity and O2 sensitivity. 
Resonance Raman spectra of the nitric oxide adducts of ferrous cytochrome 
P450cam in substrate-free form and different substrate-bound forms were reported by Hu 
et.al.61 By using isotopic substations of 15N and 18O, the axial vibrations were assigned. 
The  (Fe-NO) stretching mode and Fe-NO) bending mode are assigned at 522 and 
546 cm-1, respectively.  The geometry of Fe(II)NO fragment is expected to be inherently 
bent, but can also be sensitive to the presence of different substrates. Thus, it is 
interesting to investigate the bending modes of Fe-N-O for various substrates. It is shown 
that the size of substrate can affect these modes, the larger substrate binding can lead to 
an enhancement of the Fe-N-O bending mode. 
1.4.2.3 Fe-dioxygen complex 
The study of P450-O2 adducts is a way to get direct information about the 
catalytic mechanism. However, there are lots of challenges to acquire the vibrational data 
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for the dioxygen adduct, owing to its instability; it can be easily autoxidized back to Fe 
(III) OH rapidly. In addition, for some heme proteins, it is difficult to detect the stretching 
mode of O-O bond since it is only weak enhanced in the rR spectroscopy. However, in 
the case of P450cam and selected proteins, it is found that the  (O-O) mode can be 
enhanced owing to the fact that axial ligand is thiolate, the enhancement is presumably 
attributable to altered electronic coupling involving the S-Fe-(O2
-) fragment.62 
The rR assignment of P450 dioxygen adducts was done by employing isotopic 
labelling.62-63 In the case of camphor bound P450cam, the  (O-O) and  (Fe-O2) 
stretching modes were assigned at 1140 cm-1 and 540 cm-1 by using 18O substitution, 
respectively. Both of these two modes are sensitive to the substrate size; when the 
camphor is replaced with the larger sized substrate, adamantanone, two  (O-O) modes 
can be seen at 1139 and 1147 cm -1, indicating that in the presence of adamantanone, two 
structural conformer exist.64 
1.4.2.4 Cryoradiolysis studies on intermediates in hemeprotein catalytic cycle 
Resonance Raman spectroscopy is not only used to characterize the oxy complex, 
but also can be applied to following fleeting intermediates in the catalytic cycle including 
peroxo-, hydroperoxo- ferric forms. Radiolytic reduction in frozen solutions is an 
effective method for trapping and studying the unstable catalytic intermediates in P450s. 
Usually, radiolysis of a protein solution can produce lot of radicals which can lead to 
diverse products depending on the solvent condition; however, using a frozen solution, 
one can avoid such obstacles because the diffusion in solid matrix is limited.65 Thus, the 
cryoradiolysis studies on frozen samples made accumulating the active intermediates 
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possible. The irradiation on hemeprotein frozen solution can be conducted at 77K and 
irradiated by  ray which is usually a 60Co source to generate the free electrons in 
presence of some organic solvent such as glycerol and ethylene glycol. This method was 
first pioneered by Martyn Symons in 1980s,66 and more recently defined and used 
extensively by Hoffman and Sligar and coworkers.67 
The general process of cryoradiolysis of hemeproteins is shown in Figure 1.4.3.  
The hemeprotein is prepared in H2O or D2O buffer which both containing around 30% 
glycerol which is a good electron source during irradiation. By adding the chemical 
reductant such as sodium dithionite in anaerobic environment, the ferric iron can be 
reduced to ferrous state, then the dioxygen gas is bubbled into the protein solution at low 
temperature and quickly frozen in liquid nitrogen. Such trapped dioxygen adduct (Figure 
1.4.3 a) can be characterized by resonance Raman spectroscopy. Upon the -ray 
irradiation on the frozen solution, the electrons and free radicals were produced and the 
electrons can migrate to the Fe-O-O fragment, at this temperature, only electrons can 
move but the proton and other species are restricted. At this point, the ferric peroxo 
species (Figure 1.4.3 b) can be generated and characterized. For the next stage, to allow 
the proton transfer to generate the hydroperoxo form (Figure 1.4.3 c), the samples need to 
be carefully annealed at higher temperature, the precise temperature could be detected by 
EPR. Ideally, subsequent annealing further allows the transfer of another proton to 
facilitate O-O bound cleavage to yield compound I (Figure 1.4.3 d) or eventually neutral 
compound II species (Figure 1.4.3 e), but usually they are too reactive to trap.  
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Figure 1.4.3 Process of cryoreduction of heme proteins. 
1.5 Nanodiscs Technology application in Cytochrome P450 
The self-assembled Nanodisc system is considered as a versatile tool to study 
structure and function of membrane proteins by rendering them soluble in aqueous 
solution while still providing them a native like bilayer environment to keep function 
active.68 This system provides possibilities for measuring membrane-bound cytochrome 
P450s which previously suffered limitation on using soluble P450s only. Moreover, 
d 
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assembly of membrane proteins is achieved by using this technique. It allows detailed 
analysis from spectroscopic and kinetic methods which is extremely helpful to 
understand the mechanism of P450’s catalytic cycle. So far, numerous membrane bound 
P450s have been incorporated in nanodisc and characterized by rR spectroscopy. For 
example, nanodisc incorporated CYP3A4 shows a fully spin-state conversion upon type-I 
substrate binding.69  In addition, the nanodisc system is useful to isolate the unstable 
catalytic intermediates in cryogenic methods.  
Nanodiscs consist of an engineered scaffold protein that surrounding the lipid 
domains which plays a key role in keeping protein homogenous and soluble, Figure 1.5.1 
shows a schematic view of a nanodiscs. To approach this, the target membrane protein is 
solubilized in detergent with phospholipids and scaffold protein. By adding hydrophobic 
Bio Beads, the target protein self-assembles into a lipid bilayer discoid, the size being 
dependent on the length of scaffold protein. The advantage of nanodisc, such as small 
size, less light scattering and faster diffusion, allows careful characterizations of P450 
enzymes in a native like environment. 
 
 
Figure 1.5.1 Schematic view of a nanodisc.  
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It is also possible to incorporate the target P450 with a reductase in one nanodisc, 
which better mimic the interaction in membrane environment.70 One successful case is 
the generation of cytochrome P450 reductase (CPR) and CYP3A4 in the same nanodiscs 
(Figure 1.5.2). Thus, starting with solubilizing both proteins in detergent, once the Bio 
Beads are removed, nanodiscs can be assembled in different ways. There are several 
possibilities that different types of nanodiscs are generated; it could be the empty 
nanodiscs, nanodiscs with single protein incorporated (either CPR or CYP3A4), or both 
properly incorporated. Desired products can be separated by using several different 
columns, e.g., firstly, a size exclusion column is applied to the mixture to obtain the 
nanodiscs with right size (some get proteins incorporated and some are empty), then the 
fractions are applied on a Nickel affinity column, which can selectively bind the CYP3A4 
incorporated nanodiscs, then the eluted fractions are loaded into a 2’ 5’ ADP column 
which allows binding of CPR incorporated nanodics, finally, both CYP3A4 and CPR 
incorporated nanodicscs products can be washed out from this column. This is amazing 
because it is able to study a protein with the reductase partner in isolated membrane. You 
can never study those in aqueous solution because different kinds of aggregate. 
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Figure 1.5.2 Process of the self-assembly of CYP3A4 and CPR into Nanodiscs.70  
However, this approach requires generating a large excess of proteins 
incorporated in nanodiscs, with low overall yield. So recently, a new alternative approach 
was described by Dr. Sligar’s group, by directly incorporating of CPR into a performed 
population of CYP3A4 nanodiscs,  a stable and fully functional complex could formed 
within several minutes at 37 Celsius degree.71 The optimized ratio between CPR: 
CYP3A4 is found to be 2:1, when the ratio is 1:1, only 40% of 3A4 nanodisc was 
incorporated with reductase, but when at 2:1 ratio, most of CYP3A4 is involved in the 
1:1 complex. If the ratio increase further, a larger complexes with an increasing amount 
of CPR per CYP3A4 are formed. A highly active nanodiscs form with both target protein 
and reductase can be formed with high yield. Once formed, rR spectroscopy was used to 
investigate different P450 enzyme either expressed from bacteria or the Nanodiscs 
incorporated mammalian P450.  In our studies, to better understand the interaction 
between different proteins and heme environment, individual proteins such as CYP17A1 
is investigated using rR spectroscopy. 
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1.6 Overview of my research 
Generally, the main goal of my research is to use resonance Raman spectroscopy 
to study the structure and function of cytochromes P450. In our paper, the interaction 
between CYP17A1 and its redox partner cytochrome b5 was undertaken, including 
characterization of their ferric state and unstable intermediates, CYP17A1 ferrous 
dioxygen adduct in presence of cyt b5. The second project is focused on the enzymes 
which are good targets of exploration for biotechnologically useful purposes. There is 
high interest in study of the enzyme called P450 BM3 with the fact that it is covalently 
linked with its cytochrome P450 reductase, showing remarkably high monooxygenase 
catalytic activity, can functional convert fatty acid to short chain hydrocarbons or other 
commercial products. These rR studies are focus on several gatekeeper mutants of P450 
BM3 which can alter substrates binding to allow the PPI drug, omeprazole, to be 
processed. Specifically, the ferrous CO adduct are being analyzed to interrogate the effect 
of substrate binding on the distal pocket architecture.  In another project, trapping and 
characterization of crucial intermediates in peroxygenases (CYP152L1 and CYP152L2) 
by rR is performed, providing information about Compound I and Compound II 
intermediates that can directly react with substrate. Aside from those important studies, it 
is also of great interest to document any differences in the key Fe-O-O fragment of the 
“precursor” to the Compound I intermediate. In addition, a small project dealing with the 
enzyme, DGCR8, included as an appendix, the results having been recently published in 
the ACS Journal of Biochemistry.72 
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Chapter 2: Methods and material 
2.1 Expression and purification of P450cam  
The procedure for expression and purification of P450cam is summarized in this 
section, just for practice and to get familiar with the purification process, making 
preparation for collecting good quality rR data in later research work. 
2.1.1 Agents and buffer 
Trizma-HCl, Trizma base, potassium chloride, (R)-(+) camphor, potassium 
monophosphate, potassium phosphate dibasic, ammonia sulfate, sodium chloride, bacto 
tryptone, bacto yeast, LB broth, ampicillin, and antipain were purchased from Sigma-
Aldrich. Pepstatin, DNase, RNase, lysozyme, Phenylmethylsulfonylflouride (PMSF) and 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) were obtained from Amresco. Leupeptin, 
antipain, and amino levulinic acid (-ALA) were purchased from Alfa Aesar. The 
DEAE-52 (pre-swollen) anion exchange was purchased from Whatman, Phenyl 
Sepharose hydrophobic gel was obtained from GE Healthcare. 
All buffers were made with highly deionized water (>16.5 MΩ/ cm) which is 
generated by a deionizing system from Barnstead. The running buffer for DEAE column 
contained 50 mM Tris-Cl, 25 mM KCl and 1 mM camphor, pH was adjusted to 7.5. 
While the elution buffer for DEAE column was same as the running buffer except 
increasing the KCl concentration to 300 mM.  For phenyl sepharose column, the running 
buffer contained 50mM Tris-Cl, 50 mM KCl, 25% (NH4)2SO4 and 1 mM camphor, pH 
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was adjusted to 7.5. While the elution buffer was same as the running buffer but without 
adding ammonia sulfate. Potassium phosphate buffer were made by adding K2HPO4 
solution to KH2PO4 solution to bring up pH to 7.5. All buffers finally used contained 
1mM camphor. To avoid the formation of inactive form P420, all the procedures were 
done at 4°C environment. 
2.1.2 The enzyme assay and purity index 
The concentration of P450cam was determined by using the reported extinction 
coefficients of their character absorption band. In this case, the camphor-bounded 
P450cam has a 102 Mm-1 cm-1 coefficient at = 391 nm.73 According to beer’s law, 
concentration would be easily obtained.  
The UV absorbance ratio (A392/A280) was adopted to check the purity of the P450 
protein. In the substrate-bound P450cam, an Rz (A392/A280) value of an enzyme greater 
than 1.5 was shown as electrophoretically homogeneous.  
2.1.3 Expression of P450cam 
2.1.3.1 Preparation of LB agar Plates 
1.75g LB agar was dissolved in 50ml distilled water in a plastic conical flask, 
solution was heated in a microwave oven for 2 mints but pause every 15 seconds, gently 
shaking to avoid formation of bubbles. Allow the solution to cool down to room 
temperature, 50ul of 100mg/mL ampicillin was added. In a sterile environment, the 
solution was poured into plates continuously until the solution cover the plates, cool 
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down for 30mins. Transfer the transformed cells to the plates and spread the cell using 
autoclaved glass beads. Incubate the cells at 37° for overnight to allow cell growth. 
2.1.3.2 Preparation of 2YT media 
24g bacto tryptone, 15g bacto yeast and 7.5g NaCl were dissolved in 1.5L highly 
polished water in a 2L plastic bottle, water is added first to prevent micro-fog, four of 
such kind of 2L bottles were prepared. To anther 250ml plastic Erlenmeyer flask, 2.5g 
LB broth was dissolved in 80ml distilled water. All these five flasks were covered with 
aluminum foil and autoclaved for 20 minutes. Cool it to room temperature. 1.5ml of 
ampicillin was added into each four 2L plastic bottle, and solutions are stored in the cold 
room overnight. 
100uL of 100mg/mL ampicillin was added to the small flask, 1 colony of 
P450cam culture in plates grown previously was transferred into this flask. Incubate this 
culture solution at 37°C in the shaker with speed of 250 rpm for overnight.  
2.1.3.3 Bacterial growth 
15ml of culture solution grown overnight was transferred to each large plastic 
bottle, then incubate for 45 minutes at 37°C with rate of 250 rpm.  The growth of the 
cells were checked by measuring optical density (OD600) values using UV-Vis, spectra 
were taken to monitor until OD600 was 0.6~0.8. Results obtained are shown in the table 
below. 
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Table 2.1.1 Changes of OD600 values with time of cell growth. 
Time (mins) 0 40 80 120 150 170 180 
Abs at 
600nm 
0.0082 0.0142 0.0609 0.155 0.268 0.5048 0.7977 
 
1M Isopropyl β-D-1-thiogalactopyranoside (IPTG) was prepared by dissolving 
2.38g of IPTG in 10 mL water in a large tube. IPTG was stored in cold room with 
aluminum foil covered to avoid photo degradation. 
1.5mL of 1M IPTG and 167uL of 45 mg/mL aminolevulinic acid were added into 
each flask to induce protein expression. The addition of IPTG to cultures causes lacl 
repressor displacement from DNA, simultaneously inducing expression of T7 RNA 
polymerase from the chromosome. The best time to add IPTG was when the cell shows 
logarithmic growth phase, then IPTG can perform better to induce transcription. 
Aminolevulinic acid (ALA) worked as a precursor for heme synthesis, which is added to 
enhance the production of P450. Then these solutions were incubate at 24°C at the speed 
of 190 rpm for 21hrs.  
0.2g camphor was added into each flask one hour before harvest and incubated for 
another hour. Cells were harvested by centrifuging at 7000rpm for 10 minutes. Cells were 
collected in a plastic tube and stored in the freezer at -80°C. Mass of wet cells is 53.65g. 
2.1.3.4 Cell lysis 
Cell lysis was done in a lysis buffer by using sonication. To make lysis buffer, 1 
mM Phenylmethylsulfonylflouride (PMSF), 1 g/mL Leupeptin, 1 g/mL Antipain, 1 
g/mL Pepstatin, 32 units/mL DNAase, 3 units/mL RNAse, 1 g/mL Lysozyme were 
added into running buffer (50 mM Tris buffer, pH=7.4, 25 mM KCl, 1 mM camphor) to 
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dissolve the cell wall to release the protein. Assume the density of cell is 1 g/mL, the 
final lysis volume would be 3 times of cell volume, equals to 150 mL in this case. Note 
this volume included both the wet cells and lysis buffer. 
The cells were physically cracked into small pieces and transferred to a 50ml 
plastic beaker, and then cells were sonicated for 5 times for each time 1 minute to allow 
cooling down, using the power 3, 60% duty and timer on hold. In all this process, the 
cells were kept on ice to avoid frothing. The crude P450 were obtained by centrifugation 
for 90 minutes at speed of 7000 rpm, using rotor of code 03. The solution was 
concentrated to 20ml by using concentration cell. Buffer exchange was done on protein 
by adding DEAE running buffer before loading onto the DEAE anion exchange column. 
2.1.4 Purification of crude P450cam 
2.1.4.1 DEAE-52 Column 
According to manufacturer’s recommendation, the size of column should be about 
twice of cell lysis solution.  Specifically, 100 g of pre-swollen DEAE-52 resin were 
suspended in 0.5M Tris acid, pH was adjusted to 7.4 by adding Tris base. The 
supernatant fine particles were decanted after settle down for 30 minutes, this step was 
repeated for 3 times to remove all the fine particles in order to slow down the flow rate of 
column. Then the gel was degassed in a suction flask with  gentle mixing for 45 minutes, 
decant the top layer with fine particles, and a 4×25 cm column was packed. The column 
was washed with 1L of running buffer to ensure the equilibration. The crude P450 was 
loaded onto the column and washed 4 column volumes of the running buffer. The protein 
was eluted by using a salt gradient of 25 mM to 300 mM KCl with a flow rate of 2-3 
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mL/min. Fractions was collected every 2.5 mL and UV-Vis spectroscopy was used to 
check purity. The factions with Rz values >0.5 were combined and concentrated for 10 
mL for further purification. 
2.1.4.2 Phenyl Sepharose (Hi-Res) Column 
Phenyl Sepharose is a hydrophobic interaction column, the fraction of 
hydrophobic amino acid in the protein will bind to the resin in the presence of moderate 
to high concentration of salt. According to manufacturer’s recommendation, a 2×20 cm 
column for phenyl sepharose gel was prepared, and this column was equilibrated with 4 
columns volumes of  running buffer (50 mM Tris buffer, pH=7.5, 25% (NH4)2SO4, 50 
mM KCl, 1 mM camphor). Ammonia sulfate was added slowly to the protein obtained 
from the DEAE column to make it saturate, ensure the solution is clear without protein 
precipitation, diluted with running buffer if precipitation happened.  Then this ammonia 
sulfate saturated P450cam is loaded onto the phenyl sepharose column at the rate of 1 
mL/min. The column was washed with several column volumes of running buffer to 
obtain purer protein. Elute protein with elution buffer using a salt gradient of 25% ~0%. 
Fractions were collected every 3 mL and checked by UV-Vis spectroscopy. Fractions 2-
11 with Rz value > 1.4 were pooled, shown in Table 2.1.2 below, potassium phosphate 
buffer was used to exchange buffer to remove ammonia sulfate, and the protein was 
eventually concentrated to 200 L, stored in -80°C freezer. 
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Table 2.1.2 Rz values > 1.4 fractions collected from phenyl Sepharos column. 
Fractions A280 A392 Rz  
2 1.1134 1.6259 1.461 
5 1.4157 2.3335 1.648 
8 1.7204 2.7559 1.601 
11 1.5567 2.534 1.627 
 
2.2 Purification of Glycerol for cryogenic studies 
Cryogenic radiolysis reduction is an effective method to trap the peroxo-ferric and 
hydroperoxo-ferric intermediates, which is very helpful for mechanistic studies of 
Cytochrome P450. In order to stabilize these intermediates, data needs to be collected at 
cryogenic temperature in aqueous glycerol glasses. On the other hand, to prevent samples 
freezing at low temperature, glycerol is also necessary when making oxy samples, as 
preparation of this intermediate requires efficient mixing with oxygen. However, the 
commercial glycerol exhibits strong fluorescence background in rR spectrum due to the 
impurity, thus purification of glycerol is an absolute necessary for rR studies, the 
procedure is summarized in following sections. 
A low temperature apparatus used in our lab is shown in Figure 2.2.1. A double 
wall glass cell was used to keep the low temperature by continuously adding liquid 
nitrogen. Spectra were acquired using 415 nm from Kr+ laser (Coherent Innova Model 
100-K3) with a 180 back-scattering geometry, laser power is maintained at 20mW. 
Glycerol is used as solvent to form transparent glasses at 77K, in order to remove the 
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fluorescence impurities that may obscure the Raman bands, glycerol was purified by 
treating with charcoal74 and later vacuum distillation. 
2.2.1 Treatment of glycerol with active carbon 
99.5% Spectrophotometric grade glycerol and activated charcoal were purchased 
from Sigma-Aldrich. 27mL of glycerol was mixed with 0.34g activated charcoal and 
heated under a nitrogen atmosphere at 70℃ for 4 hours.  
 
Figure 2.2.1 Set up for low temperature rR measurement.75  
2.2.2 Vacuum distillation of glycerol 
In order to remove charcoal and further purification, vacuum distillation was 
applied.  The mixture obtained above was placed in a round bottom flask and then 
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connected to vacuum line. The mixture was degassed first and then the temperature was 
increased by heating very slowly in an oil bath. The glycerol starts to distill off at about 
155 °C. The first 1ml glycerol was discarded; the middle part (around 20ml) was 
collected in a 25ml flask. Figure 2.2.2 shows the set up for vacuum distillation of 
glycerol. 
 
Figure 2.2.2 Set up used for vacuum distillation of glycerol 
Another method was tried to remove the charcoal in glycerol. After glycerol 
reacted with charcoal for 4 hrs, the mixture was cooled down; 0.2mM syringe filter was 
then used to remove charcoal instead of vacuum distillation. Transparent glycerol was 
collected. Resonance Raman spectroscopy was used to check the fluorescence 
background of each sample, as shown in Figure 2.2.3, it was noticed that the vacuum 
distillation is the best method to get purer glycerol. 
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Figure 2.2.3 High-frequency resonance Raman spectra of glycerol from manufacturer 
and the purified glycerol according to the procedure above. (Measured with 415nm 
excitation line, 20mw power) 
2.3 Resonance Raman Measurement 
The Resonance Raman spectra were acquired using a Spex 1269 spectrometer 
equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton Instruments, NJ). 
The 406.7 nm and 413.1nm excitation lines from a Kr+ laser (Coherent Innova Sabre Ion 
Laser) were used to measure the ferric P450 and oxy samples. While the 441.6nm 
excitation line from a He-Cd laser (IK Series He−Cd laser, Kimmon Koha CO., Ltd.) was 
used to probe the P450 ferrous-CO form. The laser power incident on ferric samples was 
~10 mW, while the power used for ferrous-CO or ferrous-O2 samples are adjusted to ~1 
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mW. Rayleigh scattering was removed from the Raman signal by using an appropriate 
notch filter (Kaiser Optical). Owing to thermal effects arising from photon absorption and 
local heating by the laser beam, the possibility of decomposition of the samples can be 
enhanced. To overcome this problem, the samples were placed in a N2–driven spinning 
NMR tube and the spectra were collected by using a 180° backscattering geometry with a 
cylindrical lens.76 All spectra were calibrated with fenchone and data were processed 
with Gram/32 AI Software. The accumulation time for the RR spectra depended on the 
quality of protein. The basic set-up for resonance Raman instrument is shown in Figure 
2.2.4.  
 
Figure 2.2.4 Basic Resonance Raman instrument set-up. 
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Chapter 3. Studies of the interaction between CYP17 with reductase partner 
Portions of this chapter have appeared in the paper:  
Duggal, R,; Liu, Y,; Michael, C. G.; Ilia, G, D.; Kincaid, J. R.; Stephen, S. G.; ., 
“Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen 
synthesis” Biochemical and Biophysical Research Communications, 2016, 477, 202-208  
 
3.1 Introduction 
Cytochrome P450 17A1 (CYP17A1) is an important drug target for castration 
resistant prostate cancer. It is a bi-functional enzyme, catalyzing production of 
glucocorticoid precursors by hydroxylation of pregnene-nucleus, and androgen 
biosynthesis by a second C-C lyase step, at the expense of glucocorticoid production. It is 
also known that Cytochrome b5 (cyt b5) is a key regulator of CYP17 reactivity and 
androgen synthesis in vivo, but the mechanism for this effect has been the subject of 
intense debate for decades. Although its essential role of cyt b5 in the fatty acid 
biosynthetic pathways is well appreciated,77 early work with hepatic drug metabolizing 
enzymes often yielded conflicting results. For instance, Sato and coworkers suggested 
that the binding of cytochrome b5 (cyt b5) to cytochrome P450 elicited a structural change 
in the enzyme which activated product turnover, either by increasing the inherent 
catalytic rate or by inhibiting non-productive auto-oxidative shunt processes (As shown 
in Figure 3.1.1).78 Alternatively, as cyt b5 contains a bisimidazole coordinated heme, 
direct transfer of electrons from cyt b5 to P450 has been proposed.
79 In this latter role, the 
relatively high redox potential of cyt b5 (~0 mV versus Normal Hydrogen Electrode)
80 
suggests that electron transfer to ferric P450 (redox potential ~ 300 mV vs. NHE) is 
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unfavorable. Hence it was suggested that the redox function of cyt b5 involved electron 
transfer to the ferrous dioxygen intermediate which has a redox potential near 0 mV thus 
providing the “second electron” in the normal monooxygenase stoichiometry.81 In an 
attempt to differentiate between these two roles, Coon and co-workers reconstituted apo-
cyt b5 with manganese protoporphyrin IX.
82 They observed no reduced Mn-b5 in the 
presence of cytochrome P450 reductase (CPR) and NADPH, whereas iron cyt b5 was 
rapidly reduced. Hence Mn-b5 is incapable of any electron transfer to the P450. From 
their experiments on various P450 reactions they concluded that cyt b5 effects depend on 
the specific P450 in question, the substrate being examined, and molar ratio of CPR to 
P450. This suggested that their observations could not be explained solely by a simple 
electron transfer role and some effects may also be caused by possible conformational 
changes caused by cyt b5 binding. While the role of cyt b5 in drug metabolism continues 
to be explored, a more interesting and potentially critical function of cyt b5, is in human 
steroid biosynthesis. 
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Figure 3.1.1 Cytochrome P450 reaction cycle. Black arrows represent the path followed 
for CYP17A1 mediated hydroxylation chemistry, while red arrows represent the 
CYP17A1 mediated carbon-carbon scission reaction, the lyase chemistry. The first 
reduction is indicated as being carried out by CPR, while the second electron can be 
donated by either CPR or cytochrome b5.
105 
The synthesis of androgens, estrogens and corticosteroids involves multiple P450 
catalyzed reactions. Cytochrome P450 17A1 (CYP17A1) is a key player in these 
reactions, being responsible for catalyzing 17-hydroxylation of pregnenolone and 
progesterone followed by C17-C20 bond scission in a separate lyase reaction to form 
dehydroepiandrosterone (DHEA) and androstenedione (AD) respectively (shown in 
Figure 3.2.2). The hydroxylation reactions occur throughout a person’s lifetime, and 
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when a person approaches adrenarche, the hydroxylated products can be shunted towards 
the subsequent step of formation of androgenic precursors by CYP17A1 in addition to the 
production of glucocorticoids.83 The presence of membrane bound form of cyt b5 has 
been known to selectively and significantly enhance the rate of the lyase reaction.84 
Mutations of CYP17A1 surface residues: R347, R358 and K89 which are known to 
interact with cyt b5, have been shown to cause impairment of lyase activity. In a recent 
report, significant lyase impairment was shown in mice testicular Leydig cells lacking cyt 
b5.
85 Additionally, male patients with mutations causing a lack of cyt b5 present with 
pseudo hermaphroditism, while high cyt b5 expression in adrenocortical adenomas in 
Cushing’s syndrome patients has been associated with increased androgen synthesis.86 
Clearly, cyt b5 has a physiological significance in maintaining normal levels of androgen 
synthesis. The nature of this role has been long debated,84 87 88 89 with Auchus and 
coworkers studying lyase activity in recombinant yeast using apo b5 which stimulated the 
lyase reaction, leading these workers to conclude that there is no redox role.90 A similar 
report from Akhtar and coworkers mentions unpublished results demonstrating lyase 
enhancement in a reconstituted system utilizing Mn-b5. On the contrary, Estabrook and 
others demonstrated in an in vitro reconstituted system in the presence of lipids that a 
zinc substituted derivative of b5 did not stimulate the lyase activity of CYP17A1, and that 
the previous reports of rate enhancement by apo b5 are the result of transfer of the heme 
group from the P450 to apo b5 forming the holoenzyme.
91 Another property of cyt b5 that 
complicates all previous reports is the need for an intact membrane to influence the P450 
activity.92 Given the key importance of cyt b5 in the regulation of androgen synthesis, it is 
imperative that this disparity about the role of cyt b5 be solved in a reproducible system 
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representative of the membrane environment of these proteins. To this end, we employ 
the Nanodisc system to reconstitute CYP17A1, CPR and cyt b5 in controlled 
stoichiometric ratios. We reconstituted cyt b5 with manganese protoporphyrin IX and 
investigated the rate of lyase reaction by CYP17A1 in Nanodiscs, with iron containing 
cyt b5, or with Mn-protoporphyrin IX substituted form of cyt b5 (Mn-b5) and compared 
each case versus the rate in the absence of cyt b5. In humans, androgens are primarily 
derived from the 17-hydroxypregnenolone substrate, therefore we decided to investigate 
this reaction to determine whether cyt b5 is a redox donor in CYP17A1 mediated lyase 
reaction for androgen synthesis. Additionally, we probed the ferric resting state of 
CYP17A1 in the presence of native substrates to indicate formation of the b5-CYP17A1 
complex. 
 
Figure 3.1.2 CYP17A1 catalyzed reactions in steroidogenesis. 
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3.2 Experimental 
3.2.1 Assemble CYP17 in nanodisc 
The expression and purification of CYP17A1 was performed as described.93 The 
expression and purification of membrane scaffold protein and cyt b5 were performed as 
described.94 71 Both samples were prepared by our collaborator, Dr. Stephen Sligar’s 
group. To assemble CYP17 in nanodiscs, materials such as membrane scaffold proteins, 
phospholipids and bio beads need to be prepared ahead.  Among which, membrane 
scaffold proteins can be expressed and purified followed by a previous published 
protocol.95 And Bio beads we used here is called amberlite XAD-2 which can be 
purchased from Sigma Aldrich (catalog number is 21646-1). These polystyrene beads 
need to be washed with ethanol in advance and thoroughly rinsed with water. 
Phospholipid stock solutions are prepared in chloroform (50-100 mM, of 
precisely known concentration). As shown in Figure 3.2.1, to prepare a thin film of the 
proper amount of lipid, the desired precise amount of the chloroform solution of lipid was 
dispensed into a glass tube. The chloroform was removed by using a gentle stream of 
nitrogen gas to evaporate the chloroform; this was continued for ~ 4 hours in a fume 
hood. To further remove the residual solvent, the tube was placed in a vacuum desiccator 
under high vacuum overnight. Then a thin film should be seen on the wall of tube. Dried 
lipid has an opaque, white appearance. Then adding triton 100 contained buffer and 
vortex the tube, sonicate the solution in an ultrasonic bath until the solution is clear, and 
no lipid remains on the walls of the tube. The working lipid stock for the assembly 
mixture is ready. All these procedures result in a heterogeneous population of unilamellar 
58 
 
vesicles whose final size distribution is very sensitive to slightly changes in experimental 
conditions. 
 
Figure 3.2.1 Preparation of working lipid stock.  
To generate homogenous nanodiscs structure, the most key factor to success is 
having the phospholipids, scaffold protein and target protein in correct stoichiometry. If 
the stoichiometry ratio is not controlled strictly, then various other aggregates will form. 
According to previous studies, the optimized ratio between POPC and MSP1 is 65:1 at 4 
degree,96 as shown in the Table 3.2.1. To get the exact stoichiometry ratio, the 
concentration of lipids and MSP needs to be determined carefully. MSP concentration is 
determined spectrophotometrically using beer’s law using molar extinction coefficient 
18200 @ 280nm. To successfully assemble CYP17 in Nanodiscs, Final reconstitution 
molar ratio of mixture is 0.1:65:1 of CYP17A1/POPC/MSP1. 
Table 3.2.1 Idea stoichiometry of membrane scaffold protein (MSP) and target protein at 
different incubation temperature. 
 
The concentration of lipid solution is determined by phosphate analysis.97 By 
developing a calibration curve (Figure 3.2.2) of phosphate standard (Table 3.2.2), we can 
easily calculate the concentration of stock solution, here is 98.5mM. In details, the 
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solution was first heated in acidic medium to liberate the inorganic phosphate, reacting 
with ammonium molybdate to form phosphomolybdic acid, this acid can form highly 
colored molybdenum blue after reduction by ascorbic acid, which has strong absorption 
at 820 nm. 
 
Figure 3.2.2 Calibration curve of a series of standards of phospholipids. 
Table 3.2.2 Concentration of phospholipid standard prepared for calibration curve. 
nmol P uL standard 
0 0 
16.2 25 
32.5 50 
48.8 75 
65 100 
81.2 125 
97.5 150 
113.8 175 
130 200 
162.5 250 
y = 0.00615x + 0.16345
R² = 0.99883
0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
0 50 100 150
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Once we set up the reconstitution mixture in an ideal stoichiometry, the Bio Beads 
are removed to assemble the nanodiscs. As shown in Figure 3.2.3, firstly, by using a 
nickel affinity column, the empty nanodiscs was separated from the P450 Nanodiscs due 
to a histidine tag attached on the target protein. Then the further separation was done by 
loading fractions on a size exclusion chromatograph to get a correct size of CYP17 
nanadiscs monomers. The ideal size is around 10nm. The SDS-PAGE gel shows the 
target protein CYP17 was successfully incorporated into nansodics.  
 
Figure 3.2.3 Preparation of CYP17 nandiscs. 
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3.2.2 Reconstitution of cyt b5 with manganese protoporphyrin IX 
Cyt b5 was reconstituted with Mn-protoporphyrin IX according to previously 
published protocol,83 with the following changes: After performing buffer exchange with 
G-25 column to separate unbound Mn-protoporphyrin IX, the eluate was run through a 
DEAE-cellulose column, equilibrated with 25 mM Tris acetate (pH 8.0), 1 mM EDTA 
and 10 mM sodium cholate. A linear salt gradient was formed using the equilibration 
buffer supplemented with 1 M NaCl. Mn-b5 fractions which were characterized on the 
basis of their observed Rz ratios, were pooled and rigorously dialyzed against 100 mM 
potassium phosphate buffer (pH 7.4) and flash frozen in liquid nitrogen before being 
stored at 80C until use. 
3.3.3 Preparation of Raman samples 
3.3.3.1 Preparation of ferric form 
CYP17A1 incorporated in Nanodiscs in 100 mM potassium phosphate buffer (pH 
7.4) was concentrated to 200 M and 2-foldexcess of Mn-b5 was added from a 400 M 
solution in the same buffer. The resultant solution incubated at 37C for 15 min. As shown 
in Figure 3.2.4, both cyp17 and Mn b5 are successfully incorporated into nanodiscs, with 
their distinct bands. Substrate was added to each sample from methanolic stocks such that 
the final concentration was 420 M.98 Finally, ultrapure glycerol was added to a 
concentration of 15% (v/v); i.e., the final concentration of CYP17A1 was calculated to be 
85 M. The samples were flash frozen in liquid nitrogen and stored at 80C until 
analyzed. 
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Figure 3.2.4 SDS-PAGE gel of ND: CYP17 with Mn b5. 
3.3.3.2 Preparation of ferrous dioxygen adduct 
To better investigate effects of cytochrome b5 on the H-bonding interactions in the 
CYP17 distal pocket, two substrates, 17α-hydroxyprogesterone (OH-PROG) or 17α-
hydroxypregnenolone (OH-PREG) were incubated with ND: CYP17 samples in presence 
Mn b5. Samples for rR spectroscopy measurement contain 250 μM ND: CYP17, 0.1 M 
potassium phosphate, pH 7.4, 0.2 M NaCl, and 400 μM of 17α-hydroxyprogesterone or 
17α-hydroxypregnenolone (Sigma Aldrich). Solutions were prepared in distilled 30% 
(v/v) glycerol in H2O buffer. Starting with the degassing samples by connecting the NMR 
tube to the vacuum line, then refilling the argon gas. This process is repeated for three 
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times to eliminate the possibility that presence of oxygen. Samples were reduced under 
anaerobic conditions by titrating with a 0.9~1 fold molar excess of sodium dithionite in 
the presence of 6.25 μM methyl-viologen. It is important to note that the carefully 
performed titration ensures the reduction only performs on CYP17 as the redox potential 
of the enzyme is more positive than Mn b5. Each sample reduced at room temperature 
and then transferred to a dry ice-ethanol bath held at -20 °C where it was cooled for 2 
minutes. Oxy-ferrous complexes were formed by bubbling 16O2 or 
18O2 for 7 seconds, 
followed by rapid freezing in liquid N2. 
3.3.4 Resonance Raman Measurement 
To determine the effect of cyt b5 on the heme stretching modes in ferric 
CYP17A1, we employed the Mn reconstituted form of cyt b5. This was done to prevent 
interference from the heme of cyt b5 as was done previously by Mak et al in rR studies on 
CYP2B4.98 99 We acquired resonance Raman spectra after adding 2-fold and 4-fold 
excess of Mn b5. The high frequency spectra were acquired using the 406.7 nm excitation 
line from a Krypton ion laser (Coherent Innova Sabre Ion Laser) and changes in the (Fe-
S) stretching mode were investigated 356.4 nm excitation line from the same laser, a 
wavelength known to selectively enhance this mode.39 Resonance Raman spectra of 
frozen dioxygen samples were obtained using the 413.1 nm excitation line from a Kr+ 
laser, which effectively enhances internal modes of the Fe-O-O fragment. Each oxy 
sample was measured for 12hrs to obtain a better S/N signal, with a very low power 
maintained at 1mW on the sample. The rR spectra of all samples were measured using a 
Spex 1269 spectrometer equipped with a Spec-10 LN liquid nitrogen-cooled detector 
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(Princeton Instruments, NJ). The laser power was adjusted to ~10 mW. All samples were 
measured in a spinning NMR tube to avoid local heating and protein degradation. The 
spectra were collected using a 180° backscattering geometry, and the laser power was 
focused on the sample with a line image using a cylindrical lens. Spectra were calibrated 
with data acquired for fenchone and processed with Grams/32 AI software (Galactic 
Industries, Salem, NH). 
3.3 Results and Discussion 
3.3.1 NADPH oxidation and catalytic turnover of 17ahydroxypregnenolone in the 
presence of cyt b5 or Mn-b5 (Collaboration with Dr. Sligar’s group) 
 
The rates of NADPH oxidation and product formation in the presence of cyt b5 
and Mn-b5 were compared to the rates in the absence of any added cyt b5. The presence 
of cyt b5 increases the product formation rate ~5 fold, while the addition of Mn-b5 does 
not cause any change (Fig. 3.3.1 A). The rates of NADPH oxidation were close in value 
in all three cases, 54 ± 1.3 min-1 for cyt b5, 51 ± 1.0 min
-1 for Mn-b5 and 46 ± 1.9 min
-1 
for reactions in the absence of any b5. The efficiency of coupling was calculated as the 
ratio of product formation rate to the rate of NADPH consumption. This was seen to be 
maximal in the reactions with cyt b5, while reactions with no b5 and with Mn-b5 had 
similar coupling efficiency (Fig. 3.3.1 B). 
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Figure 3.3.1 Comparison of CYP17A1 catalyzed lyase reactions with 17a-hydroxy-
pregnenolone as substrate, with no cytochrome b5 present, or with Mn-b5, or native 
cytochrome b5. (A) DHEA product formation rates (B) Coupling efficiencies (calculated 
as the percent ratio of amount of product formed to the amount of NADPH consumed). 
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3.3.2 Resonance Raman spectroscopy on Mn b5 binding to ferric CYP17A1 
As was reported in an earlier work,100 binding of pregnenolone to substrate-free 
CYP17A1 causes a spin state conversion from almost pure low spin (LS) to largely high 
spin (HS) form, while binding of 17-hydroxypregnenolone generates a lower HS 
fraction. The persistence of more LS component being attributed to the tendency of the 
17-hydroxy fragment of the substrate to directly interact with the heme iron or promote 
retention of distal pocket water molecules. In the present work, additions of Mn-b5 to 
substrate-bound forms of CYP17A1, creating 2-fold excesses relative to the enzyme, 
cause relatively small increases of the LS component in these samples. This is reflected 
in the resonance Raman (rR) spectra illustrated in Fig. 3.3.2 for the samples bearing a 2- 
fold excess of Mn-b5. As can be seen in trace B, pregnenolone bound CYP17A1 
interacting with Mn-b5 shows a spectrum similar to that for the sample without Mn-b5 
(trace A); they both exhibit a strong isolated 3 mode at 1488 cm-1 and a small signal for 
LS population near 1500 cm-1. Employing a procedure developed in our laboratory by 
Mak et al., it is possible to estimate the spin state population using the intensity ratio of 
IHS/ILS equal to 1.24.101 Using this value, the HS population of pregnenolone bound 
CYP17A1 in the presence of a 2-fold excess of Mn-b5 is calculated to be 80%, close to 
the value observed in the absence of Mn-b5. Similarly, it is noted that the HS component 
changes from ~57% to ~50% when a 2- fold excess of Mn-b5 was added into 17-
hydroxypregnenolone bound CYP17A1 (Fig. 3.3.2 right panel, trace D). These remained 
nearly the same even in the presence of 4-fold Mn-b5, indicating that all of CYP17A1 
binding sites for cyt b5 have been occupied. In addition to the relatively minor effects on 
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spin state populations, as can be seen in Fig. 3.3.2, it is important to emphasize that the 
frequencies observed for both the low energy and high energy internal modes of the heme 
prosthetic group do not shift relative to those observed for the corresponding samples 
without Mn-b5, implying that the interaction with Mn-b5 does not induce significant 
structural changes of the heme macrocycle or its peripheral substituents in the substrate-
bound ferric enzyme. Though minimal effects were observed for spin state populations 
and heme structure, it is noted that association of CYP17A1 with Mn-b5 increases the 
strength of Fe-S linkage, demonstrating the formation of a CYP17A1: Mn-b5 complex. 
This is evident from viewing the inserts for the low-frequency spectra in Fig. 3.3.2, where 
the  (Fe-S) stretching modes occurring in samples with the excess Mn-b5 appear at 350 
cm-1, while those previously reported for the same samples of CYP17A1 in Nanodiscs 
without Mn-b5 appear at 347 cm
-1.100 
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Figure 3.3.2 Resonance Raman Spectra of CYP17A1 +/- Mn b5
 in 100 mM potassium 
phosphate buffer (pH 7.4) containing 15% (v/v) glycerol. The right panel shows the high-
frequency region of the acquired spectra, while the left panel shows the low frequency 
region; the spectra were acquired using the 406.7 nm excitation line from a Krypton ion 
laser, noting that the inset bands in the low frequency region were acquired with the 
356.4 nm excitation line from the same laser, a wavelength that selectively enhances the 
ν(Fe-S) stretching mode.39 Spectra traces in B and D are the resulting traces after 
subtraction of spectra obtained for samples containing the equivalent concentration of Mn 
b5 in 15% (v/v) glycerol in buffer. 
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3.3.3 rR spectroscopy characterization of ferrous dioxygen intermediates of 
hydroxylated substrates bound to CYP17 in the presence of Mn b5 
In previous rR studies on CYP17 dioxygen adduct performed by our group, 
different H-bonding interactions in the active site with a key Fe-O-O fragment of the 
enzyme intermediates are demonstrated for OH-PROG and OH-PREG, which proves to 
be a key factor that can control substrate processing.102 As mentioned earlier, CYP17 is 
able to catalyze the lyase reaction on both OH-PROG and OH- PREG cleaving the 17–20 
carbon–carbon bond to form dehydroepiandrosterone and androstenedione; however, it is 
interesting to see that androgen formation is 50-fold greater with OH-PREG than for OH-
PROG, with the rR spectra of the dioxygen adducts of CYP17 offering a plausible 
explanation for this differential behavior. As shown in Figure 3.3.3 and Figure 3.3.4, if 
we just have PROG and PREG bound in the active site, virtually identical iron oxygen 
and O-O stretching frequency. This is not surprising because they are known to dock 
similarly. However, if OH-PROG and OH- PREG are bound in the enzyme, both of the 
O-O stretching is shifting down slightly, but there is a quite significant difference in iron 
oxygen stretching modes, the (Fe-O) frequency for OH-PROG going up and the 
frequency for OH-PREG goes down, relatively to the ~535 cm-1 value seen for PROG 
and PREG. That’s important, because DFT calculations showed that hydrogen bonds to 
the proximal O of the Fe-OP-OT fragment can cause a decrease of Fe-O stretching mode 
whereas H-bonding to the terminal O will shift up the Fe-O stretching mode. More 
importantly, computational works done by Haris and Shaik show this kind of H-bonding 
promotes lyase reaction, allowing the nucleophilic attack of the peroxo intermediate on 
the 20-carbonyl.103,104 So this alone can explain why OH-PREG is much more effectively 
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transformed to lyase product than is OH PROG. So resonance Raman to be an effective 
way to detect subtle but functionally significant changes in the distal pocket environment. 
 
Figure 3.3.3 The rR spectra of PROG- and 17-OH-PROG-bound O2 adducts of ND: 
CYP17 in H2O buffer (Trace A and B, respectively). 
 
Figure 3.3.4 The rR spectra of PREG- and 17-OH-PREG-bound O2 adducts of ND: 
CYP17 in H2O buffer (Trace A and B, respectively). 
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Though the presence of redox partner Mn cyt b5 does not appear to have a 
significant effect on heme structure, based on the results present earlier in this chapter, a 
more careful rR study applied to the OH-PROG and OH-PREG bound ND: CYP17 
ferrous dioxygen complexes in presence of Mn cyt b5 was conducted here, attempt to 
detect these subtle active site structural change caused by this redox partner. Shown in 
Figure 3.3.5, is the rR spectra for the OH-PROG bound ND: CYP17 dioxygen complex 
in presence of a two-fold excess of Mn cytb5. The key (16O-16O) mode still appears at 
1131 cm-1, as confirmed by the 16O2/
18O2 difference spectrum, while the (
18O-18O) 
stretching mode occurs at 1068 cm-1 (the expected 63cm-1 isotope shift). Expansion of 
this spectral region, and comparison with the spectrum acquired with 18O2, shows 
evidence for a minor conformer of Fe-O-O fragment with the (16O-16O) mode occurring 
at 1140 cm-1, which is apparently unshifted from the values observed for OH-PROG in 
the absence of this redox partner (Figure 3.3.3). Significantly, the sample prepared 
including the Mn cyt b5 activates a new Fe-O-O conformer, with a (Fe-16O) mode at 530 
cm-1 and a corresponding (Fe-18O) mode at 501 cm-1. This suggests that the interaction 
with Mn cyt b5 causes a partial transformation to a conformer which provide an H-
bonding interaction with the proximal oxygen, a structure which favor the lyase reaction. 
Though the main compact of the redox partner was shown to be as an electron transfer 
role from earlier functional studies,105 subtle allosteric role of the Mn cyt b5 is indicated 
on OH-PROG bound enzyme. 
 
Corresponding spectral data for 17-OH PREG bound enzyme in presence of Mn 
b5 is shown in Figure 3.3.6. The (16O-16O) and (Fe-16O) modes are observed at 1135 
cm-1 and 526 cm-1, corresponding to the isotope band (18O-18O) and (Fe-18O) occur at 
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1070 cm-1 and 497 cm-1, which are unshifted from their values in the sample without the 
redox partner. Thus, addition of Mn cyt b5 does not cause any spectral difference, the lack 
of effects on the Fe-O-O fragment further suggesting that the electron transfer role of the 
redox partner dominates for this substrates. 
 
 
Figure 3.3.5 rR spectra of OH-PROG bound ND: CYP17 oxy complex in presence of 2 
fold excess of Mn b5 in mid-frequency region. Spectra were measured at liquid nitrogen 
temperature with excitation line at 413.1 nm. (A) OH-PROG bound ND: CYP17 16O2 
complex, (B) OH-PROG bound ND: CYP17 18O2 complex, (C) difference spectra: trace 
A-trace B. 
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Figure 3.3.6 rR spectra of OH-PREG bound ND: CYP17 oxy complex in presence of 2 
fold excess of Mn b5 in mid-frequency region. Spectra were measured at liquid nitrogen 
temperature with excitation line at 413.1 nm. (A) OH-PREG bound ND: CYP17 16O2 
complex, (B) OH-PREG bound ND:CYP17 18O2 complex, (C) difference spectra: trace 
A-trace B. 
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3.3.4 Discussion  
CYP17A1 is a critical enzyme in steroidogenesis, lying at the branch point of 
glucocorticoids synthesis and androgen synthesis. It performs hydroxylation on the 
pregnene-nucleus to form hydroxylated products which can either be diverted to 
glucocorticoid synthesis, or undergo a C-C bond lyase reaction to produce androgens. 
Cytochrome b5 is known to be the chief regulator of CYP17A1 reactivities in vivo, yet 
the nature of interactions of CYP17A1 with cyt b5 is not clearly understood. Cyt b5 is 
known to enhance the lyase reactions from 5 to 10 fold. Whether cyt b5 acts as an 
allosteric modulator or if it functions as a second electron donor has long been debated,88 
89 and conflicting reports from various groups are complicated by the fact that these 
studies were carried out in uncontrolled conditions where aggregation states and 
stoichiometries of interactions were not known.88 106 107 Scott and coworkers have used 
solution NMR with soluble forms of the proteins to study the conformational changes 
occurring in CYP17A1 bound to lyase substrates upon cyt b5 binding and associated them 
with an allosteric role for cyt b5,
108 102 although not directly addressing a possible redox 
role. The application of Nanodisc technology to this system is therefore an effective 
solution, enabling us to study reactions in controlled stoichiometries in a native-like 
membrane environment. 
We reconstituted cyt b5 with Mn-protoporphyrin IX, which is known to be redox 
inactive under these conditions,83 and tested the rate of lyase reaction in 17-
hydroxypregnenolone in the presence and absence of cyt b5, and also in the presence of 
Mn-b5. Reactions with Mn-b5 showed no enhancement of the rate of DHEA formation, 
which suggests very strongly that cyt b5 has a definite redox donor role in the CYP17A1 
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lyase chemistry. Importantly, presence of cyt b5 increases the coupling efficiency about 
5-fold. Given the relatively high redox potential of cyt b5 (~0 mV NHE),
81 its redox role 
is limited to reduction of the oxy-complex,82 giving rise to the nucleophilic peroxo-
species, the reactive intermediate responsible for carbon-carbon bond scission.109 110 An 
enhanced reduction rate of the oxy-complex is expected to increase the steady-state 
concentration of the peroxoanion, which in the absence of cyt b5 is depleted through non-
productive release of hydrogen peroxide. Our resonance Raman data with Mn-b5 binding 
to ferric CYP17A1 indicate no major structural changes of the heme planar modes, 
whereas on the proximal side, Fe-S bond was observed to get strengthened when Mn-b5 
was bound. Clearly, Mnb5 binds to CYP17A1, but is incapable of enhancing the lyase 
activity, the latter being enhanced if the native iron containing cyt b5 is bound. The 
ferrous dioxygen adduct of OH-PROG CYP17 in presence of a 2 fold Mn cyt b5 exhibits 
slight change in the active site, showing allosteric role of redox partner. However, the rR 
data of oxy OH-PREG enzyme with Mn cyt b5 strongly supports the electron transfer 
role. Taken together, these experiments provide strong evidence that cyt b5 is serving as a 
redox partner in CYP17A1 catalytic cycle, most likely delivering a second electron to the 
oxy-complex and facilitating formation of the peroxo-ferric complex, which recent 
evidence shows to be the catalytically active intermediate in the lyase reaction.109 This 
result is in agreement with conclusions on the role of cyt b5 in CYP2B4 catalysis.
111,89 
Although our results cannot disprove the presence of functionally important allosteric 
interactions between cyt b5 and CYP17A1, the lack of any effect of Mn-b5 on the rate of 
turnover of 17-hydroxypregnenolone, as compared with 5-fold acceleration of this 
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reaction in the presence of cyt b5, suggests that these allosteric interactions do not play 
significant role in the human CYP17A1 mediated catalysis of lyase reaction. 
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Chapter 4. Resonance Raman studies on Cytochrome P450 from Bacillus 
megaterium (P450 BM3) and some biotechnologically important mutants  
4.1 Introduction 
The cytochromes P450 comprise a huge class of heme containing 
monooxygenases which collectively exhibit a diverse range of chemical reactivity in 
numerous organisms, facilitating important physiological functions, including the 
metabolism of pharmaceuticals and various toxic compounds.9, 45 One essential catalytic 
activity of these enzymes is the insertion of an atom of molecular oxygen into a relatively 
inactive C-H bond, thereby effecting a hydroxylation reaction on otherwise inert 
substrates; e.g. fatty acids.31 Furthermore, over the past several decades, a number of 
bacterial P450s have been shown to play key roles in many physiological processes; e.g. 
antibiotic synthesis and catabolism of complex molecules (e.g. steroids). Moreover, 
typically they display diverse regio- and stereoselectivity in the oxidation of a wide range 
of substrates,112 a finding which has attracted growing attention from an industrial 
perspective, especially through use of protein engineering as an effective approach for 
important applications of microbial P450s in biotechnology. 
The bacterial enzyme P450 BM3 first isolated from Bacillus megaterium, 
catalyzes the hydroxylation and epoxidation of hydrophobic long-chain fatty acids.113 
There is currently high interest in this enzyme owing to its remarkably high 
monooxygenase catalytic activity, which results mainly from the fact that it possesses a 
covalently linked, high activity cytochrome P450 reductase (CPR) partner, such an 
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arrangement providing extremely efficient electron transfer between the CPR and the 
P450.114 Furthermore, its demonstrated ability (in wild-type and mutant forms) to 
catalyze oxidation of diverse substrates with high degrees of regio- and stereo-selectivity 
greatly enhances its potential for biotechnologically useful applications.115 Examples 
include the utility of BM3 mutants in converting testosterone to 2-hydroxytestosterone 
and 2-hydroxytestosterone,116 and particularly in producing human drug metabolites, 
such as those from PPI (proton pump inhibitor) drug molecules. These kinds of 
industrially important molecules are typically prepared by complicated and expensive 
methods of traditional synthetic chemistry.117 Indeed, much effort has already been 
devoted to studies of this particular BM3 mutants to synthesize metabolites of 
omeprazole (OMP) (Figure 4.1.1), and of other PPI molecules.118 With reference to the 
P450 BM3 heme domain crystal structure (Figure 4.1.2), the role of active site residues 
have been extensively explored,119 with residues near the active site pocket, including 
Phe87and Ala82, having been targeted in attempts to alter substrate selectivity and enzyme 
activity.120 For example, Phe87 is located over the heme cofactor and plays a key role in 
interacting with the -methyl group of the fatty acid substrate, preventing its oxidation. 
Mutating the phenylalanine provides new space close to the heme cofactor to allow 
binding of novel substrates. The A82F mutant causes moderate destabilization of the 
BM3 heme domain structure by inducing a conformational change.121 Collectively, these 
effects lead to pronounced changes in the substrate specificity profile of the F87V/A82F 
double mutant. It is of note that both of the A82F and F87V single mutants demonstrate 
affinity for omeprazole, as measured by the development of high-spin heme in these 
samples on titration with omeprazole, with Kd values of 1.67 ± 0.05 M and 49.0 ± 2.7 
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M, respectively.120 However, the combined mutations lead to much higher affinity for 
omeprazole in the F87V/A82F double mutant (Kd = 0.212 ± 0.014 M).  All of the 
mutants catalyze hydroxylation on the 5-methyl group of omeprazole, with the 
F87V/A82F double mutant being the most productive enzyme. The 5-hydroxylation of 
omeprazole is the same reaction catalyzed by CYP2C19, the major human omeprazole 
metabolizing P450.120 The effects of various alterations on the structure and environment 
in the active site of these mutants are of great interest.  
Among the many diverse spectroscopic methods, resonance Raman (rR) 
spectroscopy has proven itself to be a highly effective approach by which the active site 
environment of a heme protein can be interrogated. This technique can selectively 
enhance the heme vibrational modes by adjusting the excitation line close to the heme 
absorption bands.2, 122 Information such as oxidation state and spin state of the heme iron 
can be readily obtained using the so-called marker modes, which appear in the high 
wavenumber region of the vibrational spectrum, while the low wavenumber region can 
provide important insight into the interactions between protein residues and the 
peripheral heme groups; i.e., the vinyl and propionate substituents. This is important, 
because the relative orientation of these groups can affect the reactivity of heme.123 
Moreover, this technique is particularly useful for analyzing changes in the disposition of 
exogenous axial ligands caused by binding of substrates, and for examining differences in 
the active site environment, including distal pocket polarity and steric interactions, 
imposed by the substrate or amino acid residues.57 
In the present study, rR spectroscopy is used to probe heme structure and 
coordination environment for selected mutants (A82F, F87V and the F87V/A82F double 
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mutant) of the BM3 heme domain in their substrate-free and substrate-bound forms. The 
substrate selected is omeprazole (OMP), which was shown to bind to the mutant forms of 
the BM3 heme domain by UV-visible spectral titration, but which did not induce any 
significant shift towards high-spin heme iron in the wild type BM3 heme domain. 
Specifically, rR spectral data were acquired for the substrate free (SF) and OMP-bound 
forms of the wild type and mutant BM3 heme domains. Furthermore, the rR of ferrous 
CO adducts were also collected and analyzed  in order to interrogate how omeprazole 
substrate binding affects the vibrational modes of the Fe-CO molecular fragment, data 
which reveal important details about the active site architecture. Collectively, these 
studies provide insight on how these ‘gatekeeper’ mutants influence substrate selectivity, 
affinity and protein-heme interactions within the BM3 heme domain active site.  
 
 
Figure 4.1.1. Structure of human drug OMP (omeprazole). Hydroxylation on the 5-
methyl group is performed by engineered variants of P450 BM3 mutants. 
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Figure 4.1.2. Structure of omeprazole bound A82F/F87V double mutant of P450 BM3. 
Key residues are shown as blue sticks. Phe82 and Val87 are shown in green, close to the 
heme. Other important residues include Ser72, which participates in a hydrogen bonding 
network involving active site water molecules, benzimidazole and pyridinyl group 
nitrogens, and a heme propionate. Leu437 also hydrogen bonds to the other 
benzimidazole group nitrogen atom through its backbone carbonyl group, while Thr268 
plays a key role in proton delivery to heme iron-oxo species during the P450 catalytic 
cycle. (PDB #: 4KEY)120  
4.2 Experimental 
4.2.1 Samples preparation for rR measurement 
Samples of P450 BM3 heme domain and its mutants, generated using previously 
described procedures,120 were used to prepare samples for rR measurements. Specifically, 
50 L of 100 M P450 BM3 (heme domain) samples of the substrate-free wild type, the 
single mutants A82F and F87V BM3, and the double mutant F87V/A82F heme domains 
were transferred into NMR tubes for rR measurements. The substrate stock solution was 
prepared by dissolving 9 mg of omeprazole in 450 L of DMSO to reach a concentration 
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of 56.4 mM. The substrate/enzyme ratio is 5.6/1 in substrate-bound samples. The sample 
was centrifuged and the transparent supernatant solution was transferred to an NMR tube 
for rR measurement.  
The carbon monoxide complexes of the heme domain of ferrous BM3 (wild type 
and mutant heme domaims) were prepared with and without the substrate, omeprazole. 
To prepare these samples, NMR tubes were sealed with a rubber septum and CO gas was 
introduced to the solution using a long needle for 20 minutes to remove oxygen. Then 
samples were reduced with a 2-fold excess of degassed sodium dithionite solution and 
CO gas was further bubbled for an additional 10 minutes before measuring the rR 
spectra. 
4.2.2 Resonance Raman measurement 
The ferric sample was measured with the 406.7 nm excitation line from a Kr+ 
laser (Coherent Innova Sabre Ion Laser) while the spectra of the Fe(II)-CO adducts were 
acquired with the 441.6 nm line from a He-Cd laser (IK Series He−Cd laser, Kimmon 
Koha Co., Ltd.). All spectra were measured using a Spex 1269 spectrometer equipped 
with a Spec-10 LN liquid nitrogen-cooled detector (Princeton Instruments, NJ). The slit 
width was 150 μm and the laser power incident on ferric samples was ~10 mW, while the 
power used for ferrous-CO samples was adjusted to ~1 mW at the samples to prevent CO 
photo-dissociation. Rayleigh scattering was removed from the Raman signal by using an 
appropriate notch filter (Kaiser Optical). The samples were placed in a N2–driven 
spinning NMR tube and the spectra were collected by using a 180° backscattering 
geometry with a cylindrical lens to achieve a line focus on the tube. Spectra were 
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calibrated with data acquired for fenchone and processed with Grams/32 AI software 
(Galactic Industries, Salem, NH).  
4.3 Results and discussion 
4.3.1 Effects of omeprazole binding on the ferric form of WT P450 BM3 heme 
domain and its mutants 
The rR spectra of the ferric wild-type substrate-free enzyme and its omeprazole-
bound form are shown in Figure 4.3.1. The spectrum of the substrate-free sample (trace 
A) exhibits the oxidation state marker mode ν4 at 1372 cm-1 and the ν3 and ν2 spin-state 
markers at 1501 and 1585 cm-1, respectively, confirming the presence of a pure six 
coordinate low-spin (6cLS) species. The spectrum of the BM3 heme domain with 
omeprazole (trace B) exhibits a spectral pattern essentially identical to that of the 
substrate-free sample, indicating that the addition of omeprazole causes no changes to the 
heme spin state or to the macrocyclic core structure. As shown in Figure 4.3.1, 
comparisons of both the low-wavenumber and high-wavenumber rR spectral data also 
confirm the lack of significant changes induced by omeprazole, as judged by the virtually 
identical rR spectra shown in traces A and B. Thus, the rR spectra of ferric wild type 
BM3 heme domain show no indication of heme spectral changes upon addition of OMP, 
a finding which is consistent with earlier published results, where optical titrations 
showed no evidence for binding of OMP to WT BM3.120 
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Figure 4.3.1 rR spectra of various form of wild type P450 BM3. (A) substrate-free form 
(B) OMP-bound. Left panel shows the low-wavenumber region while the right panel 
shows the high-wavenumber region. 
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Figure 4.3.2. High wavenumber rR spectra of substrate-free ferric P450 mutants and 
their substrate bound forms. (A) A82F substrate-free form. (B) Omeprazole bound A82F. 
(C) F87V substrate-free form. (D) Omeprazole bound F87V. (E) A82F/F87V double 
mutant substrate-free form. (F) A82F/F87V double mutant omeprazole bound form. All 
spectra were normalized to the 4 mode. 
86 
 
4.3.2 Active site structural changes of P450 BM3 mutants induced by omeprazole 
binding 
The high-wavenumber rR spectrum of substrate-free A82F BM3 heme domain 
mutant is shown in Figure 4.3.2 (A), where assignments of the observed bands are given, 
all of which are consistent with earlier published data for CYP101A1 (the camphor 
hydroxylase P450cam) and the general behavior of  (C=C) modes.124-125 The strongest 
peak occurs at 1373 cm-1 and is assigned as the oxidation state marker band, 4, 
confirming that the protein is in the ferric state. The spin state marker bands, and 
10, occur at 1501 cm-1, 1582 cm-1 and 1637 cm-1 respectively, consistent with a six 
coordinate, LS heme iron. However, weaker peaks at 1486 cm-1 and 1568 cm-1 indicate 
the presence of a small percentage of a high spin five coordinate (5cHS) species. It is 
possible to estimate the spin state population in this sample using previously derived 
relative rR scattering cross section of the v3 modes for the 6c LS and 5c HS species, as 
determined for both forms of P450cam, and as described by Mak et al.101 Using this 
procedure, the HS percentage is calculated to be 30%. In contrast with most other 
substrate-free P450s (which often yield a more extensive LS population), this A82F 
mutant retains a significant percentage of HS state, even after having been passed through 
a Lipidex column to facilitate removal of any lipid substrate. X-ray crystallography 
data120 reveal that the structure of the substrate-free A82F heme domain is significantly 
different from that of the substrate-free WT BM3 heme domain. Specifically, a 
displacement of the FG helix region is seen, which disrupts the contacts between the FG 
helices and the I helix, leading to the reorientation of hydrophobic residues within the 
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active site and a conformational change in the P450. It appears likely that this dramatic 
structural change may affect the organization of the cluster of water molecules in the 
distal pocket above the heme, as a consequence of the movement of I helix; i.e., 
hydrogen-bonding networks are disrupted and rearranged, altering the positions of water 
molecules. Thus, the substrate-free A82F mutant exists naturally in equilibrium between 
the LS and HS state.  
Typically, binding of substrates to the cytochromes P450 causes a ferric heme 
iron spin state change from 6cLS towards 5cHS owing to the disruption of the water 
cluster in the distal pocket and through the displacement of the axial water ligand. 
Usually, there is a corresponding increase in the heme FeIII/FeII redox potential that helps 
facilitate electron transfer to the heme iron from the relevant redox partner.126 As shown 
in Figure 4.3.2 (B), addition of OMP to the A82F mutant causes significant changes in 
the high-wavenumber rR spectrum. Two 3 modes, observed at 1486 cm-1 and 1501 cm-1, 
show that the OMP-bound form also exists in an equilibrium between the 5cHS and 6cLS 
forms, respectively. The relative intensity of the HS 3 (1486 cm-1) band is larger 
compared to the LS 3 (1502 cm-1) mode, indicating a higher population of the HS 
component, estimated to be 65%.101 This spin state mixture is also reflected in alterations 
in the 2 and ν10 bands; i.e., the 2 bands occur at 1568 cm-1 (HS) and 1582 cm-1 (LS). In 
the WT P450 BM3 protein, the Ala82 residue is located in a peripheral position in the 
active site. However, mutating Ala82 to a bulky phenylalanine leads to a substantial 
conformational change, altering positions of key active site residues (Figure 4.3.3), In 
particular, the Phe87 residue adopts a different conformation in which its side chain 
flipped from a parallel position to a near perpendicular orientation relative to the heme 
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plane, as compared to wild type BM3 heme domain in its complex with N-
palmitoylglycine substrate (NPG) (PDB: 1JPZ). This structural change provides a closer 
contact of the phenylalanine side chain with the pyridinyl moiety of OMP, inducing a 
reorientation of substrate, leading to an increased HS component.  
Figure 4.3.3 Stereoviews of A82F/OMP BM3 heme domain active site (PDB 4KEW in 
red) with WT/NPB BM3 active site (PDB 1JPZ in blue). Key amino acid residues in 
lines. 
Similar studies of the F87V P450 BM3 heme domain mutant were conducted, 
with the high-wavenumber region of the substrate-free form (Figure 4, trace C) exhibiting 
features characteristic of the ferric state, with the ν4 oxidation state marker occurring at 
1373 cm−1. The spin state marker bands, including ν3 at 1501 cm−1, ν2 at 1583 cm−1 and 
ν10 at 1637 cm−1, are indicative of a pure 6cLS state, consistent with heme iron 
coordination by a water molecule associated with a distal pocket cluster of water 
molecules.127 The feature observed at 1621 cm−1 is confidently assigned to the ν(C=C) 
stretching mode of the peripheral vinyl group, with this wavenumber corresponding to an 
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in-plane vinyl stretching mode.128 Binding of OMP to F87V BM3 causes a partial 
conversion from 6cLS to 5cHS, as shown in Figure 4.3.2 (trace D), with the 5cHS 
markers being observed at 1486 (ν3), 1568 (ν2), and 1622 cm−1 (ν10) (the last being 
overlapped with vinyl v(C=C) mode(s)). The weak 6cLS markers seen at 1501 and 1583 
cm−1 persist in the spectrum, confirming the presence of residual low spin species. 
Overall, the increase of the HS component (56%) indicates the ability of this mutant to 
allow access of OMP to the heme distal pocket.  
Turning attention to the substrate-free A82F/F87V double mutant, the enzyme 
exhibits a pure ferric 6cLS state, as evidenced by an isolated band at 1500 cm-1. Binding 
of OMP to the double mutant gives rise to a relatively large HS component, exhibiting a 
ν3 feature at 1486 cm-1, as shown in Figure 4.3.2 (trace F). The intensity analysis 
referenced above16 provided a calculated ratio of 68% of the HS form. It is noted that the 
wavenumbers of the vinyl stretching modes in the spectra of substrate-bound samples are 
difficult to establish because of their overlap with the HS ν10 mode; i.e., the ν10 mode for 
5cHS is expected to occur near 1623 cm−1.129,130 
Summarizing the results obtained for the ferric proteins in the high-wavenumber 
region of the rR spectra, while binding of OMP is rigidly restricted for WT BM3, all of 
the F87V, A82F and F87V/A82F mutants show a considerable spin state conversion upon 
binding OMP, consistent with entry of OMP into the active site. However, a significant 
percentage of 6cLS species exists, possibly resulting from the incomplete expulsion of 
water molecules from the pocket and retention of an axial water ligand in minor 
proportion of the enzymes. However, a substrate conformation in which the pyridinyl 
nitrogen atom of OMP is in a position to coordinate with the heme, thereby generating a 
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LS species, cannot be ruled out. The percentages of the HS fractions for all of the BM3 
heme domain samples (in substrate-free and OMP-bound forms) are summarized in the 
Table 1. These results obtained from resonance Raman data are in good agreement with 
earlier published binding data based on optical studies of OMP binding. These Kd data 
are also included in Table 1, clearly demonstrating that the F87V, A82F and combined 
F87V/A82F double mutations enable this fatty acid hydroxylase enzyme to act as a 
catalyst for OMP hydroxylation. The A82F substrate-free sample shows ~30% HS 
content, whereas the DM shows negligible HS content after treatment with Lipidex. It is 
likely that the introduced Val87 residue in the F87V/A82F double mutant alters distal 
pocket organization such that the spin-state equilibrium is perturbed as a result of 
reorganization of water molecules in the environment of the heme. 
Table 4.3.1. P450 BM3 wild-type and mutant heme domain spin state populations, 
calculated by cross section ratio 1.24. The table shows the high spin proportion of the 
different mutants, along with Kd values for OMP binding to mutant heme domains. NA 
indicates that no evidence of binding was found. 
  Protein substrate resonance Raman (%HS) Kd values from optical data
120 
Wild type SF              0%  
Wild type OMP              0%     NA 
A82F SF 30%  
A82F OMP 65% 1.67± 0.05 
F87V SF  0%  
F87V OMP 56% 49± 2.7 
A82F/F87V DM SF               0%  
A82F/F87V DM OMP 68%             0.212± 0.014 
 
 
 
Low frequency Resonance Raman spectra. The low-wavenumber region of rR 
spectra can provide important information about the disposition of heme peripheral 
groups. Specifically, the propionate groups usually exhibit their vibrational modes in the 
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region of ~360-380 cm-1, providing insight into their interactions with the protein, mainly 
involving hydrogen bonding interactions with the surrounding amino acid residues which 
causes rR shifts to higher wavenumbers. In the 400-440 cm-1 region, the bending modes 
of vinyl groups occur, with the lower wavenumber mode (near 410 cm-1) corresponding 
to the in-plane orientation, while the higher wavenumber mode (near 440 cm-1) is 
associated with an out-of-plane distortion.131, 132 In addition, structure sensitive in-plane 
and out-of-plane (i) heme deformation modes occur in this region.133, 134 
As shown in Figure 4.3.4, trace A, the substrate-free A82F BM3 low-
wavenumber rR spectrum shows the normal heme skeletal modes: 7 (676 cm-1), 15 (753 
cm-1) and 8 (344 cm-1). According to more detailed assignments of the rR spectra of 
other P450s, such as P450cam,125 the bands observed at 364 cm-1 and 380 cm-1 are 
assigned to the bending modes of two heme propionate groups, while the band at 429 cm-
1 is assigned to an out-of-plane vinyl bending mode, which can be correlated with the 
vinyl stretching mode observed at 1621 cm-1 in Figure 4. The binding of OMP causes an 
increase in the intensity of the 365 cm-1 bending mode of propionate group(s), indicating 
structural reorientation and a perturbed hydrogen bonded propionate group(s). A similar 
pattern was observed in the spectrum of substrate bound P450 BM3, this mode is 
originally assigned as an out-of-plane 6 mode by Deng et al,135 which is induced by 
binding of the substrate. However, Schelvis and coworkers132 assign this substrate activated 
mode to be a new propionate mode, result from a disrupted H-bonding between 7-propionate and 
lysine amino acid residue (Lys69), supported by crystallographic data.136 Finally, as confirmed by 
Mak et al by employing a deuterated heme and a carefully performed deconvolution procedure, 
this feature is believed to contain contributions from both the 6 and propionate mode.125 
92 
 
Another bending mode of the propionate group(s) is observed at the same position as in 
the substrate-free form (at 380 cm-1). Two bending modes of vinyl groups are detected at 
414 cm-1 and 430 cm-1.124 Additionally, it is noted that a heme out-of-plane mode 7, 
occurring at 312 cm-1, is activated after binding of OMP, which apparently induces an 
out-of-plane distortion of the heme, i.e. the enhancement of out-of-plane modes arises 
from an out-of-plane heme distortion of the equilibrium structure of the heme 
macrocycle.26,27,137 
Similar patterns are seen for the F87V mutant and for the A82F/F87V double 
mutant heme domains (Figure 4.3.4, trace C-F). In both cases, introduction of OMP 
(Figure 4.3.4 trace D and F) causes significant change in their low-wavenumber regions 
compared to the substrate-free forms.  
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Figure 4.3.4. Low frequency rR spectra of substrate-free ferric P450 mutants and their 
substrate bound forms. (A) A82F substrate-free form. (B) Omeprazole bound A82F. (C) 
F87V substrate-free form. (D) Omeprazole bound F87V. (E) A82F/F87V double mutant 
substrate-free form. (F) A82F/F87V double mutant omeprazole bound form. All spectra 
were normalized to the 7 mode. 
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4.3.3 Ferrous CO P450 BM3 wild-type and mutant (A82F, F87V, A82F/F87V DM) 
and their interaction with substrate. 
Cytochromes P450 are able to bind gaseous diatomic ligands, such as CO, NO 
and O2, among which the ferrous-CO adducts are relatively more stable, facilitating 
detailed rR spectroscopic studies.59 This is fortunate, because the behavior of the 
observable ν(Fe-C) and ν(C-O) stretching modes of the Fe-C-O fragment can provide 
quite useful information about steric hindrance and H-bonding interactions imposed upon 
the Fe-C-O fragment by the substrate or by surrounding amino acids within the active 
site.138 The effects of such interactions are directly related to corresponding interactions 
with the Fe-N-O and Fe-O-O fragments of the more unstable NO and O2 adducts. The 
interaction between the heme iron and the bound CO involves heme dπ back- bonding to 
the π* orbital of the CO ligand, strengthening the Fe-C bond while weakening the C-O 
bond; this is reflected by an increased Fe-C stretching wavenumber and a decreased ν(C-
O) stretching mode, leading to the well-documented inverse linear correlation plot, 
discussed in more detail later.57,139 
The low wavenumber rR spectra of the ferrous CO adduct of wild type substrate-
free BM3 heme domain is shown in Figure 4.3.5 (Trace A, left panel). The most intense 
band in this region, besides the 7 mode, is the (Fe-C) band seen at 471 cm-1. In 
accordance with earlier work performed, including 13CO labeling, the band at 559 cm-1 is 
assigned to the (Fe-C-O) bending mode, with the corresponding ν(C-O) mode occurring 
at 1943 cm-1, as shown in Figure 4.3.5 (Trace A, right panel). 
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A similar spectral patten is seen in the low wavenumber region of the rR spectra 
of wild type BM3 with OMP (Figure 4.3.5, trace B), where the (Fe-C) stetching mode 
occurs at 471 and the ν(C-O) mode at 1943 cm-1. Thus, introduction of OMP into the 
wild type BM3 does not cause any significant change in the distal pocket, which is 
consistent with other documented lack of evidence for the binding of OMP to the wild-
type BM3. It is emphasized that this seemingly “redundant” information is actually 
useful, because it is possible that binding of a substrate may not cause significant changes 
in the spin state of the ferric form, but much less likely that binding of substrate would 
not affect the modes of the Fe-C-O fragment in the P450. Thus, the absence of changes in 
these modes provides stronger confirmation of the lack of OMP binding in the active site. 
 
Figure 4.3.5 The rR spectra of ferrous CO adducts of wild type BM3, the low frequency 
spectra is shown in left panel, and the high frequency is in right panel. (A) Wild type 
substrate-free (B) wild-type OMP bound. Spectra were measured with 442 nm excitation 
line and normalized to the v7 modes. 
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Figure 4.3.6 The low frequency (left panel), middle frequency (mid-panel) and high 
frequency (right panel) rR data of ferrous CO adduct of P450 BM3 mutants. (A) A82F 
substrate-free form. (B) Omeprazole bound A82F. (C) F87V substrate-free form. (D) 
Omeprazole bound F87V. (E) A82F/F87V double mutant substrate-free form. (F) 
A82F/F87V double mutant omeprazole bound form. All spectra were normalized to the 
7 mode. 
97 
 
Figure 4.3.6 shows the rR spectra of the ferrous CO adduct of the BM3 mutants in 
both the low wavenumber (left panel) and the high wavenumber regions (right panel). It 
is important to note that binding of OMP to the ferrous CO forms of all these mutants has 
no impact on the heme core modes, including the propionate modes and the orientation of 
vinyl modes (Figure 4.3.6, left panel). This means that the bound substrate OMP mainly 
interacts with the Fe-CO fragments within the active sites of the BM3 mutant heme 
domains.  
While the effect of OMP binding on the heme moiety is minimal, binding of OMP 
has a significant impact on the Fe-C-O fragments of all of these mutants. As seen in the 
low-wavenumber spectrum of the substrate-free form of the A82F ferrous CO adduct 
(Figure 4.3.6, trace A), a single ν (Fe-CO) stretching mode occurs at 472 cm-1, with the 
corresponding ν(C-O) mode being seen at 1947 cm-1, It is notable that these values are 
quite similar to those of the substrate-free form of the WT heme domain (i.e., 472/1943 
cm-1). However, addition of OMP causes substantial changes, as shown in Figure 4.3.6, 
trace B. While the 472/1947 cm-1pair persists, a new ν (Fe-CO) stretching mode is seen at 
484 cm-1, with its corresponding ν(C-O) mode occurring at 1935 cm-1; i.e., a new Fe-C-O 
conformer is formed upon OMP binding. It should be recalled that, while the Phe87 
residue of the WT protein (with NPG substrate bound) lies almost parallel to the heme 
plane (Figure 4.3.3), this residue assumes a nearly perpendicular orientation with respect 
to the heme plane for the A82F mutant; i.e., presumably the newly observed conformer 
(with the 484/1935 cm-1 pair of Fe-C-O modes) results from this reorientation of the 
Phe87 fragment.  
98 
 
In the case of the F87V BM3 mutant, it is interesting to note that while the ferric 
substrate-free heme domain showed no evidence for heterogeneity, there are two ν(Fe-
CO) stretching modes seen in the spectrum of the CO adduct, observed at 470 and 480 
cm-1, with the corresponding ν(C-O) modes occurring at 1947 cm-1 and 1936 cm-1, 
respectively (Figure 4.3.6, trace C). Based on relative intensities, the ν(C-O) mode at 
1947 cm-1 corresponds to the 470 cm-1 (Fe-CO) mode and the 1936 cm-1 feature is 
correlated with the 480 cm-1 (Fe-CO) mode. Obviously, this behavior is consistent with 
the well-documented inverse wavenumber relationship. As the less bulky valine was 
introduced to replace the phenylalanine sidechain, a more open distal pocket provides an 
environment with greater opportunities for conformational flexibility of the Fe-C-O 
fragment. The effect of OMP binding on the F87V mutant, now devoid of the intrusive 
phenyl group, has a rather dramatic effect on the Fe-CO linkage, leading to a high 
population of a fragment participating in a relatively strong H-bonding interaction, as 
evidenced by the 485/1933 cm-1 pair of bands, an interaction presumably associated with 
the OMP substrate. 
Given this apparent key role for the F87V mutation in regulating active site 
environment, it is not surprising that the vibrational mode patterns for the Fe-C-O 
fragment for the double mutant are virtually identical to those observed for the F87V 
mutant (within a couple wavenumbers and having quite similar relative intensities). The 
most likely candidates for a strongly polar group associated with substrate binding are the 
methyl ether substituent of the pyridinyl frament or, perhaps less likely, the S=O group, 
either of which is likely to associate with a distal pocket water molecule, polarizing it to 
serve as an effective H-bond donor.  
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The wavenumbers of the ν(Fe-C) and ν(C-O) stretching modes for the ferrous-CO 
adducts of all of the P450 BM3 heme domain variants studied here, including the 
substrate-free and OMP-bound forms, are collated in Table 4.3.2.  The resulting plot of 
the ν(Fe-C) vs ν(C-O) values, (Figure 4.3.7) yields the expected inverse correlation.140 In 
Figure 4.3.7, the correlation line for nitric oxide synthase, NOS, (green line) 141,142 is 
displaced above the P450 line, owing to correspondingly higher ν(Fe-C) stretching modes 
that result from the fact that a proximal pocket tryptophan residue provides an H-bond 
donor fragment to the proximal thiolate ligand of NOS, weakening the Fe-S linkage. 
Below this line lies the line for P450cam (blue line),59,143,144 which possesses a more 
strongly electron donating thiolate proximal ligand, leading to relatively high ν(Fe-S) 
stretching modes occurring near 350-355 cm-1.39 The data points for the P450 BM3 heme 
domain and mutants yield a line close to that of P450cam (red line), but with a slightly 
greater slope, reflecting a wider variation in distal pocket polarity; this observation is 
consistent with the higher polarity of the OMP substrate compared to the collection of 
less polar substrates in the study of P450cam.  
In conclusion, the resonance Raman data presented here show that the binding of 
OMP causes a substantial increase in distal heme-pocket polarity in the BM3 F87V, 
A82F and F87V/A82F mutant heme domains. The addition of OMP has no effect on the 
Fe-C-O fragment in the wild-type P450 BM3 heme domain, confirming earlier results 
indicating that OMP does not enter the heme pocket.120 The F87V mutation has a strong 
impact on the modes of the Fe-C-O fragment, an observation consistent with the 
structural changes enabled by this mutation within the heme distal pocket. In general, the 
data acquired here highlight the ability of these mutations to effectively influence protein 
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structure and so to alter the substrate selectivity of BM3, as demonstrated by their 
introducing catalytic activity towards OMP and related PPI drugs.120, 118 These rR studies 
provide important new structural insights into BM3 mutants that have gained novel 
functions in PPI drug metabolism through changes to P450 conformational state and 
active site organization produced through introduction of the A82F and F87V mutations, 
respectively. These BM3 mutants catalyze the 5-hydroxylation of OMP (and oxidation of 
other PPI drugs), generating the same metabolite produced by human P450 2C19, as well 
as other human P450-type metabolites (e.g. from rabeprazole and lansoprazole) that 
should make these drug metabolites more readily available as standards for tests required 
for FDA compliance. 
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Table 4.3.2 The frequencies of ν(Fe-C) and ν(C-O) stretching modes for P450 BM3 
proteins. The numbers in the column represents points in Figure 4.3.7. 
  P450 BM3  (Fe-C) cm-1 (C-O) cm-1 
1 wild type substrate-free 471 1943 
2 wild type + OMP 471 1943 
3 A82F substrate-free 472 1947 
4 A82F + OMP 472 1947 
5 A82F + OMP 484 1935 
6 F87V substrate-free 470 1947 
7 F87V substrate-free 480 1936 
8 F87V+ OMP 474 1945 
9 F87V+ OMP 485 1933 
10 A82F/F87V substrate-free 473 1945 
11 A82F/F87V substrate-free 483 1933 
12 A82F/F87V + OMP 475 1945 
13 A82F/F87V + OMP 483 1934 
  CYP101     
14  substrate-free           464 1963 
15  + norcamphor  473 1947 
16  + adamantanone  474 1942 
17  + camphoroquione  476 1941 
18  + fenchone  480 1945 
19  + camphor 481 1940 
20  + tetramethylcyclohexanone  485 1934 
 NOS 
  
21 nNOS Substrate-free 487 1949 
22 nNOS Substrate-free 501 1930 
23 nNOS + Arg 503 1929 
24 nNOS + OH-Arg 502 1928 
25 NOSFL substrate-free 487 1945 
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Figure 4.3.7. Diagrams showing an inverse correlation for P450 BM3 (wild type and 
mutants), P450cam and NOS in substrate free and substrate bound form. The numbers 
represent proteins listed in Table 4.3.2. The red triangles show points for P450 BM3 (red 
line), the blue diamonds for P450cam (blue line), and green squares for NOS (green line).  
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Chapter 5 Resonance Raman investigations on cytochromes P450 peroxygenase: Ole 
T (CYP152L1) and P450 Staph (CYP152L2) 
5.1 Introduction 
While the majority of known cytochromes P450 use NAD(P)H-dependent 
reductase systems and the O2-bound intermediate to eventually produce Compound I, 
several P450s have evolved to exploit the so-called “peroxide-shunt” pathway, where 
reaction of the ferric heme with H2O2 directly produces “Compound 0”, which rapidly 
converts to Compound I, a mechanism which bypasses any need for partner reductases, 
prompting the designation of peroxygenases for these P450s, the mechanism is shown in 
Figure 5.1.1 (grey arrows).145 In contrast to other monooxygenase P450s that use the 
oxygen as oxidizing agent (double-headed arrow in Figure 5.1.1), these peroxygenases 
utilize H2O2 to facilitate substrate oxidation to replace the need for solubilized oxygen 
and the complex reductase system. Needless to say, this efficient peroxide activation 
route has attracted great interest for biotechnological purpose.146 
Two of these, one from Bacillus subtilis, CYP152A1 (P450BSβ), and the other, 
from Sphingomonas paucimobilis, CYP152B1 (P450SPα), employ H2O2 to efficiently 
catalyze the hydroxylation of long chain fatty acids (FAs).145, 147  While P450SPα catalysis 
is highly specific, with nearly exclusive hydroxylation at the α position, P450BSβ 
catalyzes hydroxylations at both the α (40%) and β (60%) positions.145 Another 
peroxygenase, recently isolated from Jeotgalicoccus and characterized by Rude et al,148 is 
41% identical in sequence to P450BSβ and 37% to P450SPα. The authors designated this 
104 
 
enzyme as a CYP152 P450 family member (i.e., CYP152L1), whose commonly used 
name is Ole T. While reasonably close in sequence with the other CYP152 members 
mentioned above, Ole T displays a much different catalytic activity. Like P450SPα and 
P450BSβ, Ole T also has high affinity for long chain FAs; however, instead of catalyzing 
hydroxylations at α and β positions, Ole T catalyzes a remarkable transformation of FAs, 
converting them into linear and branched chain terminal alkenes involving a C-Cα bond 
cleavage process, as shown in Figure 5.1.2.149 
 
Figure 5.1.1 The catalytic mechanism for Ole T and general P450.149 
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Figure 5.1.2 The C-C cleavage reaction catalyzed by Ole T. 
In order to better understand the stark differences in catalytic activities, direct 
comparisons have been made for crystal structures of Ole T,149 and P450BSβ,
145 revealing 
a similar substrate binding mode in which the fatty acid carboxylate is tethered via 
electrostatic interactions to an active site arginine (Arg245). A most interesting difference 
in the two structures is the replacement of Q85 in the P450BSβ enzyme with a potentially 
H-bonding H85 in the case of Ole T. Attempts to relate the effects of this residue 
replacement to possible mechanistic differences have been made. However, our 
collaborator, Professor Thomas Makris and his group, have shown that introducing the 
H85Q mutation into Ole T does not diminish conversion of C20 FA to nonadecene. These 
and other spectroscopic and kinetic studies have led Professor Makris to consider other 
possible mechanisms.150 In presence of per-deuterated eicosanoic acid (C20D FA) with 
excess H2O2, a Compound I species is accumulated to a high level with its optical 
spectroscopic characters being similar to those observed spectra (Soret band 370nm and 
an additional band at 690nm).52 In a parallel experiment, the protiated native substrate 
bound Ole T failed to permit accumulation of Compound I. Such an apparent kinetic 
isotope effect strongly suggests that a hydride removal from C position initiates fatty 
acid decarboxylation performed by Compound I.149 The newly proposed mechanism is 
shown in Figure 5.1.3, following by H abstraction from C20 fatty acid by Compound I, a 
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substrate radical and a Fe (IV) Compound II species are generated, either a substrate 
biradical or carboncation is produced involving a single electron transfer to Compound II, 
which can be further rearranged to generate the alkene products.151 
 
Figure 5.1.3. Proposed mechanism for Ole T decarboxylation reaction catalyzed by P450 
Compound I.  
The other CYP152 family enzyme, CYP152L2 from Staphylococcus massiliensis, 
named as P450 staph (abbreviated as CYP-SA), is a close orthologue to the P450 Ole T 
CYP152L1 with 61% identity shared. Both enzymes have highly similar properties and 
perform highly similar reactions. Although here are a couple of differences on the protein 
surface, the active site is very similar. The one main difference is that CYP-SA is much 
more stable than Ole T, this is a huge advantage as Ole T has a big precipitation/P420 
issue upon thawing/freezing and reduction process, thus trapping the unstable 
intermediate on this analogy could be extremely informative on both enzymes. 
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The general purpose of this project is to use resonance Raman spectroscopy to 
track how well the O2 driven pathway works with peroxygenase enzymes, as there is 
always a large interest in seeing if Ole T can turn over with O2 and electrons, which could 
be much easier for biofuel generation in organisms since it is difficult to leverage H2O2 in 
cells. Thus, rR experiments are planned on Ole T (CYP152L1) and CYP-SA 
(CYP152L2) in presence of per-deuterated eicosanoic acid substrate, which will be quite 
useful in providing information, such as potential heme macrocycle distortions and 
reorientation of peripheral substituents, it will be also interesting to investigate how the 
substrate position affects the disposition of the diatomic ligand, including the Fe-CO and 
Fe-O-O fragments, which can lead to a better understanding of both the Fe-S strength in 
the proximal side and the H-bonding environment in distal pocket. 
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5.2 Experimental 
5.2.1 Sample preparation 
The following samples were kindly provided by our collaborator, Dr. Thomas 
Makris from the University of South Carolina University, including:  1) 290 M Ole T, in 
clean ES complex with deuterated eicosanoic acid (C20D FA) in 250 mM phosphate 
buffer (pH=7.5) with 250mM NaCl, prepared in H2O. 2) 200 M CYP-SA in 200 mM 
phosphate buffer (pH=7.5), containing 30% purified glycerol (v/v).  
Some of P450s and/or fatty acid substrate precipitates out of solution upon 
thawing, and those samples were centrifuged to eliminate the precipitations before use. 
Ferric samples were prepared by directly transfering 50uL of protein to an NMR tube. 
The ferrous samples were prepared by adding degassed sodium dithionate solution into 
the argon equilibrated protein samples, where monitoring the 642nm Q band in Uv-vis 
spectra, until it completely disappears. This is all done at room temperature.  
5.2.1.1 Ferrous CO samples for rR measurement 
The ferrous CO adducts of both Ole T and CYP-SA enzymes were prepared in 
exactly the same way with the presence of methyl viologen to facilitate reduction (molar 
ratio of protein to MeV is 5:1). Specifically, 50L of CYP-SA protein was placed in 
NMR tube (WG-5 Economy, Wilmad) which was sealed with a rubber septum (Sigma 
Aldrich, Milwaukee, WI). After degassing with CO gas for 15 minutes, the proteins were 
reduced by injecting a stoichiometric amount of sodium dithionite solution, which is 
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prepared freshly in degassed buffer. Then the sample was further equilibrated with CO 
gas by bubbling for an additional 10 mintues to ensure full converstion.  
5.2.1.2 Ferrous dioxygen adduct preparation 
Oxy samples were prepared by using the vaccum line in our lab, on which the 
NMR tube could be easisly connected with sealed connection parts. Starting with the 
ferric substrate-bound samples, vaccum was applied to the tube first and then refilling 
with Ar gas, repeating this process for several times to ensure there is no presence of 
oxygen. Sodium dithionite solution was titrated to the enzyme through a long needle 
attached to a syringe, until the 642 nm band disappeared in the Q region of Uv-vis 
spectra. Again, the enzyme is reduced in presence of Methyl Viologen. Then, reduced 
CYP-SA sample tubes were transferred to a dry ice-ethanol bath held at -20°C to be 
cooled down for 1 minute. Oxy-ferrous complexes were made by bubbling 16O2 or 
18O2 
for 10 seconds, followed by rapid freezing in liquid N2 to avoid auto-oxidation. 
However, lots of efforts were taken on making oxy Ole T under different 
conditions; i.e., 16O2 or 
18O2 gas was bubbled into the reduced Ole T at different 
temperatures to find the suitable conditions of oxy complex formation, including -20°C, -
15°C, -12°C, -10°C and 4°C, with a mixing time ranging from 10-20s. The procedure of 
making oxy compound is exactly same as state above. 
5.2.2 Resonance Raman Measurement 
The spectra of ferric samples was obtained using a 406.7nm excitation line and 
the spectra of ferrous and oxy samples were measured using 413.1nm line, both lines 
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being provided by a Kr+ laser (Coherent Innova Sabre Ion Laser). And the spectra of the 
ferrous CO sample, were acquired with the 441.6 nm excitation line from a He-Cd laser 
(IK Series He-Cd laser, Kimmon Koha CO., Ltd.). The RR spectra of all samples were 
measured using a Spex 1269 spectrometer equipped with a Spec-10 LN liquid nitrogen-
cooled detector (Princeton Instruments, NJ). The slit width was 150 μm, and the laser 
power for ferric sample was kept around 10mW, whereas for the ferrous CO and oxy 
complex, the power was adjusted to ~1 mW. All samples were measured in a spinning 
NMR tube and a cylindrical focusing lens to avoid local heating and protein degradation. 
It is emphasized that, the oxy adducts were measured at 77K, in a home-designed glass 
dewer filled with liquid nitrogen. Spectra were calibrated with fenchone and processed 
with Gram/32 AI software (Galactic Industries, Salem, NH). 
 
5.3 Results and Discussion 
5.3.1 Results of ferric Ole T protein with deuterated eicosanoic acid (C20D fatty 
acid)  
The high-frequency rR spectrum of substrate-free (SF) Ole T is shown in Figure 
5.3.1 (trace A). The peak occurs at 1373 cm-1, assigned as the oxidation state marker 
band, 4, indicating the protein is in ferric state. The spin state markers 3 and 2 mode 
occurs at 1502 and 1581 cm-1, confirming the presence of a pure six-coordinated low spin 
(6cLS) form. The modes observed at 1619 and 1628 cm-1 were assigned to two vinyl 
stretching vibrations. Addition of the substrate, C20D fatty acid, to the enzyme caused a 
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large degree of conversion from LS to HS component, as reflected by the relatively 
higher intensity of high spin 3 (1488 cm-1) band than the low spin 2 mode (1502 cm-1); 
the HS component is estimated to be 70% by employing the value of IHS/ILS determined 
to be 1.24.101 This spin state mixture is also reflected by alterations in the 2 and ν10 
bands; i.e., the 2 bands occur at 1565 cm-1 and 1637 cm-1. However, it is difficult to 
estimate the mix spin state mixture from the 10 band since the high spin state 10 band 
usually overlaps with the vinyl stretching mode which occurs at 1623 cm-1.  
 
 
Figure 5.3.1 The high frequency rR spectra of Ferric Ole T protein. (A) substrate-free 
Ole T (B) C20D-bound Ole T. Spectra were normalized to the ν4 mode at 1374 cm-1. 
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The low-frequency rR spectrum of SF Ole T is shown in Figure 5.3.2 (trace A). 
The assigned heme skeletal modes are ν7 (676cm-1), ν15 (752 cm-1) and ν8 (348 cm-1). A 
shoulder of ν7, appearing at 695 cm-1, can be allocated to 20. According to the complete 
assignments of other heme proteins, including globins and Cytochromes P450, the bands 
observed in the region of 365-380 cm-1 are typically assigned to the bending modes of the 
heme propionate groups,125 though they are more properly interpreted as heme 
deformation modes that involve significant contributions from the propionate bending 
coordinates as well as δ (Cβ-CH3) motions: herein, the bands occuring at 372 and 382 cm-
1 are assigned as heme propionate bending modes. Likewise, bands appearing between 
400-440 cm-1 are assigned to “vinyl bending” modes,128 with frequencies observed at 414 
and 426 cm-1, values which are in good agreement with the observations of two vinyl 
stretching modes observed in the high frequency region, as mentioned earlier. 
Binding of the C20D fatty acid substrate does not induce a significant change in 
the heme skeletal vibrations, 8, 15 and 7, at 348 cm-1, 752 cm-1, 676 cm-1 respectively, 
in the low-frequency region, as shown in Figure 5.3.2 (trace B). However, it can be seen 
that one propionate bending mode occurs at lower frequency (372 cm-1) decreased 
relative intensity compared to the other higher frequency bending mode. It is generally 
agreed that this lower frequency propionate bending mode is associated with the greater 
hydrogen-bonding network between the propionate and surrounding amino acid residue. 
One possible explanation for this is the H-bond network is disrupted and thus showing 
the deactivation of one propionate bending mode or, more likely that both propionates 
have similar environments.  
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Figure 5.3.2 The low frequency rR spectra of Ferric Ole T protein. (A) substrate-free Ole 
T (B) C20D-bound Ole T. Spectra were normalized to the ν7 mode at 676 cm-1. 
5.3.2 Results of ferric CYP-SA protein with deuterated eicosanoic acid (C20D fatty 
acid)  
The high-frequency RR spectra of ferric state P450-SA is shown in Figure 5.3.3, 
noting that the band appearing at 1468 cm-1 is attributable to glycerol. The ν4 mode was 
seen at 1373 cm-1, which indicates the sample is in ferric state. Furthermore, the spin state 
marker, ν3 mode at 1504 cm-1 shows the presence of 6cLS state. There is also a relatively 
higher intensity 5cHS component observed (ν3 at 1490 cm-1). This spin state mixture is 
also reflected by alterations in the ν 2 and ν10 bands; i.e., the ν 2 bands occur at 1571 cm-1 
and 1584cm-1, which the ν 10 bands occur at 1632 and 1642 cm-1. It is also important to 
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notice two vinyl stretching mode occurs at 1623 cm-1 and 1632 cm-1 (the last being 
overlapped with ν10).  
The low-frequency region of rR spectra of CYP-SA is shown in Figure 5.3.4. The 
assigned heme skeletal modes are ν7 (675cm-1), ν15 (754 cm-1) and ν8 (345 cm-1). A strong 
shoulder of ν7 appearing at 694 cm-1 can be allocated to 20. According to the complete 
assignments of other heme proteins, including globins and Cytochromes P450, the bands 
observed at 365 and 380 cm-1 are assigned to the bending modes of the heme propionate 
groups,125 Similarly, bands appearing between 400-440 cm-1 are assigned to “vinyl 
bending” modes, which occurs at 412 and 425 cm-1. It is interesting to note that in this 
C20A bound sample, the intensity of heme out-of-plane modes are relatively strong; i.e., 
7 and 12 occurs at 322 cm-1 and 492 cm-1, which implies a greater oop distortion of 
heme macrocycle compared to Ole T.152 Collectively, it can be concluded that CYP-SA 
heme cofactor possesses a ruffled, highly distorted posture reflected by relatively intense 
oop modes seen in rR spectra. 
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Figure 5.3.3 High-frequency rR spectra of P450-SA. Spectra were measured at room 
temperature with excitation line at 406.7 nm. 
 
Figure 5.3.4 Low-frequency rR spectra of P450-SA. Spectra were measured at room 
temperature with excitation line at 406.7 nm. 
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5.3.3 Ferrous-CO samples of Ole T and CYP-SA characterized by resonance Raman 
Spectroscopy 
One of the most important factors that control the reactivity of Cytochromes P450 
is the strength of linkage between the heme iron and the proximal cysteine thiolate. 
Interrogation of the ferrous CO adducts of heme proteins using rR has been proven to be 
an effective probe of this linkage, including the proximal active site environment, 
especially H-bonding interactions with surrounding amino acid residues. Basically, the 
strength of Fe-S ligand can be reflected from trans-axial exogenous ligand with 
measurable changes in the internal modes for the Fe-CO fragment, which depend on 
extent of dπ (Fe) to CO (π*) backbonding donation. In order to better understand the 
structural factors involved in CYP152 family, the rR spectroscopy is performed on 
ferrous CO CYP152 complexes. 
The rR spectra of ferrous CO Ole T substrate-free complex is shown in Figure 
5.3.5, trace A, with the left panel showing the low frequency spectra, indicating the 
presence of two Fe-CO fragments, with the (Fe-C) frequencies observed at 467 and 479 
cm-1. The presence of two conformers is confirmed by the observation of the two 
corresponding (C-O) modes being observed at higher frequency at 1939 and 1957 cm-1 
(Figure 5.3.5, trace A right panel). In contrast, binding of a long chain C20D fatty acids 
to Ole T with its polar carboxylate group lying close to the heme iron, gives rise to only 
one distinct Fe-C feature, which appears at 476 cm-1, with its correlated C-O stretching 
mode occurring at 1941 cm-1 (Figure 5.3.5, trace B). It can be suggested that a more 
constrained distal pocket is formed as the bulky long chain fatty acid is anchored into the 
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active site, allowing less space for Fe-CO movement, consistent with only one 
conformer. Similarly, only one Fe-CO stretching mode (479 cm-1) is detected for the 
C20D bound CYP-SA CO complex, with the associated (C-O) mode seen at 1949 cm-1 
(Figure 5.3.6). 
To gain more insight into the electrostatic and H-bonding effects in the active site 
of the enzyme, a plot of the inverse backbonding correlation line between (Fe-C) and 
(C-O) frequencies is shown in Figure 5.3.7. The data points for Ole T and CYP-SA 
samples are shown in yellow and purple dots, respectively, along with similar plots for 
other previously reported cytochrome P450cam (in blue line),143,59, 139,139 mammalian 
nitric oxide synthase (NOS) in grey lines142,141 and the histidine ligated myoglobin (Mb) 
variants with differing distal residues (orange line).153,154,155,156 The values for all the 
points are listed in Table 5.3.1. The data points for these myoglobin variants are highly 
informative; as is well-known, the His64 residue in wild-type Mb provides a weak H-
bond donor to the Fe-CO fragment, and replacing the His64 with a more hydrophobic 
residue can lead to a downshift data points along the backbonding line. However, 
mutation of His64 to a stronger H-bond donor residue can shift the point up (left).157 
Thus, the increased polarization effect in distal pocket can be reflected by the position of 
data points. Compared with the histidine ligated myoglobin variants, P450cam possesses 
a stronger donor thiolate ligand from a cysteine side chain, which is expected to decrease 
v(Fe-C) frequency via sigma competition, thus showing a backbonding line below the 
Mb line. Consistent with the trend, the NOS enzymes, which have a proximal cysteine 
residue, exhibit a line between these two lines owing to the fact that they possess a 
proximal H-bond donor with tryptophan residues, this lead to a lowered thiolate donor 
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strength, thus exhibiting a separate line between P450cam and Mb backbonding lines. 
Considering all the data points for CYP152L enzymes herein, it is important to notice all 
these data points fit very well on the correlation line for P450cam, showing a similar Fe-S 
strength and proximal environment. On the other hand, the C20D bound samples yield a 
higher position along the line, suggesting the increased polarity in the distal pocket, 
which can be well postulated that the H-bonding interaction is enhanced by the 
introduction of the polar carboxyl group of the substrate. 
 
Figure 5.3.5 rR spectra of Ole T CO complex. Spectra were measured at room 
temperature with excitation line at 441.6 nm. Left panel shows Low-frequency region, 
middle panel presents high frequency, and right panel shows the region where the C-O 
stretching mode occurs. 
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Figure 5.3.6 rR spectra of C20D fatty acid bound CYP-SA complex. Spectra were 
measured at room temperature with excitation line at 441.6 nm. Left panel shows Low-
frequency region, middle panel presents high frequency, and right panel shows the region 
where the C-O stretching mode occurs. 
 
Figure 5.3.7 backbonding correlations of FeCO adducts in different heme proteins which 
yielding various axial ligands: blue line – thiolate ligated P450cam, grey line – thiolated 
ligated with Tryptophan backbone H bond NOS, orange line- myoglobin variants with 
differing distal residues. The data points for Ole T CO complex are shown in yellow dots 
while the CYP-SA CO data point is shown in purple.  
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Table 5.3.1 values of all the points for plotting Figure 5.3.5 are listed below. References 
are cited in the content. 
P450 cam (C-O) cm-1 (Fe-C) cm-1 
substrate-free  1963 464 
+ norcamphor 1947 473 
+ adamantanone  1942 474 
+ camphoroquione  1941 476 
+ fenchone  1945 480 
+ camphor  1940 481 
+tetramethylcyclohexanone  1934 485 
Mb   
WTSW 1937 515 
WTSW pH=8.4 1944 512 
WTSW pH=7.0 1947 507 
WTSW pH=2.6 1966 489 
WTh 1941 508 
WTp 1944 508 
H64Qh 1945 507 
H64Gh 1965 492 
H64ASW 1966 490 
H64VSW 1967 488 
H64ISW 1968 490 
H64LSW 1965 490 
V68Th 1961 491 
V68Np 1922 526 
F46VSW 1967 489 
L29F/H64QSW 1938 513 
H64V/V68Tp 1984 479 
nNOS   
substrate-free 1949 487 
substrate-free  1930 501 
+ Arg  1929 503 
+ HO-Arg 1928 502 
iNOS substrate-free  1945 487 
iNOS + Arg  1906 512 
CYP152 enzyme   
Ole T substrate free 1957 467 
Ole T substrate free 1939 479 
Ole T C20D bound 1941 476 
CYP-SA C20D bound 1949 479 
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5.3.4 rR investigations on ferrous-dioxygen adduct of Ole T and CYP-SA  
As discussed earlier in this dissertation, the rR technique applied to oxy 
intermediates of CYP17 had shown the impressive potential to detect the subtle active 
site structure perturbation especially the H-bond interactions with the Fe-OO fragment.91 
Specifically, H-bonding to the proximal O of the Fe-OP-OT fragment causes decrease of 
Fe-O stretching mode, in this case, the H-OP interaction is expected to inhibit bond 
cleavage and prolong the lifetime of the peroxo intermediate, allowing nucleophilic 
attack on susceptible substrates leading to the C-C bond cleavage lyase reaction.158 H-
bonding to the terminal O will shift up the Fe-O stretching mode, and the H-OT 
interaction promotes O-O bond protonation and cleavage, finally yielding Compound I 
intermediate, which effective mediate hydroxylation reactions.159 Needless to say, such a 
powerful technique is able to detect subtle structure variations that can dramatically 
impact enzyme function. 
The original plan is to prepare and trap the ferrous dioxygen adducts of Ole T and 
characterize it and following intermediates in the P450 enzyme cycle with rR 
spectroscopy. However, although a lot of effort was spent trying to prepare and trapp the 
dioxygen adduct, under different conditions, as summarized in section 5.2.1.2. Since all 
the samples are freezing immediately after mixing with oxygen, the complex formation 
can only be examined by rR spectroscopy which the samples could be measured in liquid 
nitrogen temperature using home design setup in our lab. After long rR spectral 
acquisition time on these frozen samples, there was no evidence obtained for dioxygen 
adduct formation. These disappointing results led us to reconsider various possibilities for 
the failure to generate fragile oxy samples. The first step of the cycle begins with the 
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substrate-bound ferric samples, where rR spectra is earlier shown in Figure 5.3.1. The 
presence of 70% HS form in this sample eliminates our worry about whether this organic 
substrate could reach sufficient concentrations to sheathe the highly concentrated enzyme 
(200 M), However, it is important to notice that these samples quite readily generate 
precipitation due to the excess amount of organic fatty acid substrate present. So the 
reduction process on substrate-bound form were carefully checked before dioxygen 
bubbling. The collected rR data for ferrous form is shown in Figure 5.3.8, the intense 
sharp peak 4 in high frequency region occurs at 1358 cm-1, indicating the P420 form 
formation (inactive form of enzyme which the CO adduct exhibits a Soret band at 
420nm); i.e., the ferrous P450 form typically has a 4 occuring at 1347cm-1. A similar 
pattern is seen in the camphor bound CYP101 P420, the 4 mode shifts from 1372 to 
1361 cm-1 upon the reduction.127 Under this situation with quick P420 formation upon 
reduction, trapping oxygen adduct would be difficult. 
 
 
Figure 5.3.8 rR spectra of ferrous substrate-free and C20D bound enzyme. Left panel 
shows low frequency and right panel shows the high frequency region. 
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While the other CYP152 enzyme, CYP-SA, shares highly similar active site 
structure with Ole T, it is much more stable than Ole T, without any P420 conversion and 
substrate precipitation issues. Thus, the study the dioxygen adduct of CYP-SA is an 
alternative way to gain useful information. The 413.1 nm excitation line from Krypton 
laser is selected as the closest line to the Soret band of oxy CYP-SA (428 nm). Due to the 
low S/N of these frozen samples, the modes of Fe-O-O fragment were identified using 
difference traces of O2 isotope, the resultant spectra being seen in Figure 5.3.9. As seen in 
trace C, an (Fe-16O) occurs at 513 cm-1 with the (Fe-18O) seen at 486 cm-1, which is 
shifted down by 27 cm-1 (calculated to be 25cm-1). Usually, the frequency of  (Fe-O) can 
be modulated by direct H-bonding interactions between the bound oxygen and 
neighboring residues. It is interesting to notice that the frequency of Fe-O is unusually 
low, compared with other Cytochrome P450s whose frequencies typically occur in the 
region 526-542 cm-1.91, 63, 109 It can be postulated that the significant reduction in the  
(Fe-O) frequency is caused by a relative strong distal hydrogen bonding to the proximal 
oxygen of Fe-OP-OT fragment, this could be consistent with a lowering of the tendency 
for the O-O bond cleavage, allowing the enzyme to utilize a peroxo intermediate as the 
oxidizing species. One puzzling observation is that, there is no appreciable O-O 
stretching mode detected in the higher frequency region (1000-1700 cm-1). It is believed 
that the distal interactions can alter the mechanism of enhancement by changing the 
energy level of Fe-O2 molecular orbital, thus the silence of O-O stretching mode could be 
either attributed to the ruffled heme plane, or it can be suggested that the Fe-O-O unit is 
highly bent, showing steric interactions between Fe-OO fragment and steric bulk of 
substrate/residues of distal pocket. 
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Figure 5.3.9 rR spectra of P450-SA oxy complex in mid-frequency. Spectra were 
measured at liquid nitrogen temperature with excitation line at 413.1 nm. (A) CYP-SA 
16O2 complex, (B) CYP-SA 
18O2 complex, (C) difference spectra: trace A-trace B. 
In summary, the results presented here provide a general idea of the effect of the 
C20D fatty acid on the active site structure, including the spin state conversion and vinyl 
and changes of protein interaction with vinyl and propionate groups of heme. The rR data 
of ferric OleT indicates the introduction of bulky fatty acid substrates cause the 
reorientation of propionate group, while the CYP-SA C20D bound data strongly 
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suggesting a ruffled, highly distorted heme cofactor. Both of the CO complexes of Ole T 
and CYP-SA indicate a strong Fe-S linkage like P450cam, while the presence of the 
C20D fatty acid substrates bring the additional H-bonding in the distal pocket. Though 
not yet successful in trapping the Ole T dioxygen complex, the ferrous dioxygen adduct 
of the Ole T analogue, CYP-SA, seems to suggest the presence of a strong hydrogen 
bond donor to the proximal oxygen of Fe-OP-OT fragment, suggesting a mechanism that 
could involve a stabilized peroxo species is the oxidizing species. 
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Chapter 6 Conclusion 
Heme proteins play an important role in many biological processes, they all 
recruit a heme cofactor into the enzyme active site to display a remarkably diverse range 
of chemical activity. These include the electron transport proteins, oxygen transport 
proteins, heme sensor proteins and the most interesting, catalytic proteins, which can 
effect quite remarkable chemical transformations under physiological conditions. Among 
all these heme containing enzymes, cytochromes P450 and peroxidases are of great 
interest for study in our lab. Within the catalytic cycles of these proteins, highly reactive 
intermediates are generated; these actually dictate the chemical reactivity, but historically 
it has proven very difficult to structurally characterize these fleeting species. Fortunately, 
resonance Raman spectroscopy has emerged as a very effective technique to study 
structural changes of these crucial intermediates.  
 Cytochromes P450 exist in many organisms throughout the biosphere, 
from bacteria to humans. However, most of the significant progress in understanding the 
mechanisms of P450s was made by studying the bacteria P450s, as they are soluble and 
easily isolated compared to the mammalian P450s. Chapter 2 describes the methods used 
for the expression and purification of a bacteria P450, CYP101A1, which hydroxylates 
the substrate, camphor. In this work, CYP101 was used as a vehicle to gain important 
experience in protein expression and purification as well as providing a relatively stable 
enzyme to gain valuable expertise in acquiring resonance Raman spectral data. Indeed, 
this enzyme has served as the paradigm of cytochrome P450 structure and function 
during the past 5 decades.  
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Cytochrome P450 is a broad class of heme monooxygenase enzymes, which 
catalyze various oxidative transformations. Mammalian P450s can be classified into two 
main sub-classes, one is involved with drug metabolism and the other comprises enzymes 
that participate in steroidogenic processes. Chapter 3 of this dissertation focuses on one 
of these steroidogenic P450s, CYP17A1, which not only catalyzes hydroxylation 
reactions, but also promotes C-C bond cleavage reactions; i.e., lyase reactions. 
Cytochrome b5 is known to be a key regulator of this latter activity by a mechanism that 
is not well understood. Here, nanodisc technology is used to prepare functional dyads of 
these proteins and resonance Raman spectroscopy is effectively employed to structurally 
characterize protein-protein interactions. Results of careful functional studies show no 
impact of (redox inactive) Mn b5 on the lyase reaction, indicating mainly an electron 
transfer role for cytochrome b5 in the lyase reaction. While resonance Raman 
spectroscopic studies showed that Mn b5 binding does not affect the heme skeletal modes,  
they do reveal a slight increase the strength of the Fe-S bond, as well as a weakening of  
the Fe-O bond of OH-PROG bound CYP17, while that of the enzyme complex with the 
lyase substrate, OH-PREG, remains unaffected.  
Chapters 4 and 5, focus on cytochromes P450 that are attracting growing attention 
from an industrial prospective, especially the exploring of protein engineering as an 
effective approach for important applications in biotechnology. The bacterial fusion 
enzyme, P450 BM3 (CYP102A1), which includes a fused reductase domain, is a good 
target of exploration for biotechnologically useful purposes, especially its A82F, F87V 
and the double mutant, which enhance the affinity for the human P450 drug metabolite, 
omeprazole (OMP). Here  again, as in Chapter 3,  rR spectroscopy was useful in showing 
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OMP does not bind in the active site of WT BM3, does bind and cause rR-detected 
structural changes within the active sites of the A82F, F87V and double mutations of 
P450 BM3.  
 Chapter 5 describes initial studies conducted to investigate P450 peroxygenase 
enzymes [CYP152L1 (Ole T) and CYP152L2 (CYP-SA)], both of which are able to 
convert fatty acids to terminal alkenes. They use a “peroxide-shunt” pathway, generating 
crucial intermediates via reaction of the ferric heme with H2O2, following a mechanism 
which bypasses any need for partner reductases, an attractive activation route for 
biotechnological applications. The acquired rR data documented a 70% HS component 
upon binding of the substrates, also showing that the introduction of bulky fatty acid 
substrates causes the reorientation of a propionate group on Ole T enzyme, while 
inducing a ruffled, highly distorted heme cofactor in the CYP-SA C20D bound enzyme. 
Spectra of the CO complexes of Ole T and CYP-SA indicate a strong Fe-S linkage, 
comparable to that of P450cam. In future studies it will also be of great interest to 
document any differences in the key Fe-O-O fragments of the “precursor” to the 
Compound I intermediate. Though unsuccessful in trapping the Ole T dioxygen complex, 
preliminary studies of the ferrous dioxygen adduct of the Ole T analogue, CYP-SA, 
provides evidence for a strong hydrogen bond to the proximal oxygen of Fe-OP-OT 
fragment, an observation that is consistent with a stabilized peroxo intermediate.  
Overall, the extensively rR studies performed here on quite different heme 
proteins demonstrate how useful such studies can be in revealing how enzyme reactivity 
can be profoundly affected by subtle structural changes. 
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Appendix: Analysis of Heme Iron Coordination in DGCR8: The Heme-Binding 
Portions of this chapter have appeared in the paper:  
Girvan, H. M,; Bradley, J. M.; Cheesman M. R.; Kincaid, J. R,; Liu, Y.; Czarnecki, 
K,; Fisher, K,; Leys, D,; Rigby, S. E. J,; Munro, A. M,; “Analysis of Heme Iron Coordination 
in DGCR8: The Heme-Binding Component of the Microprocessor Complex” Biochemistry, 
2016, 55, 5073–5083 
 
1. Background of DGCR8  
This is a small project which cooperating with Dr. Munro’s group, which aims to 
use resonance Raman spectroscopy in our laboratory as an assist tool to help identifying 
the coordination environment of DGCR8. The work was publish in ACS Journal of 
Biochemistry.72 
Micro RNAs are a small non-coding RNAs which are only ~22 nucleotides which 
plays a significant role in the regulation of cellular function in animals and plants and in 
certain viruses. They can prevent translation process by binding with messenger RNA.160 
As shown in Figure A1, mature miRNA needs to be processed from primary miRNA by a 
series of cleavage steps to reach the activation in gene regulation. Firstly, a pri-miRNA is 
cleaved in the nucleus into an intermediate called the precursor miRNA by the RNase III 
enzyme Drosha, this process will not happen with the assistance of DGCR8. Then the 
precursor miRNA was transported to cytoplasm and finish the further cleavage steps with 
the help of different types of enzymes.161  
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Figure A1. Process of generating mature microRNA. 
Earlier studies reported spectroscopic data consistent with bis-cysteine ligation of 
the heme iron and suggested that a single heme was coordinated by Cys352 side chains 
from both DGCR8 proteins in a dimer.162 
DGCR8 is the first example of a heme binding protein with two endogenous 
cysteine side chains serving as axial ligands. This special the heme environment of 
DGCR8 attracts more interest and thus resonance Raman and Uv-vis spectroscopy are 
effective tools to probe the structure in different forms. 
2. Uv-vis spectroscopic analysis of DGCR8.  
The Uv-vis spectra of ferric state of DGCR8 is shown in Figure A2 (red line), it is 
showing a hyperporphyrin spectrum with the main soret peak at 450 nm and the second 
feature at 367 nm. In the visible region, the ferric heme exhibits a broad absorption 
feature with a peak at 557 nm and a shoulder at 586 nm. This is consisted with the 
spectrum of a ferric bis-Cys heme ligated model complex.  
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The reduced DGCR8 is shown in green lines with the Soret band at 427 nm and 
531, 559 nm band in visible region. Dawson’s group conducted a lot of work on 
spectroscopic investigations of heme axial coordination using a mutated myoglobin with 
no axial heme coordination from the polypeptide. Using either cyclopentanethiol to 
mimic bis-cysteine coordination, they determined the spectroscopic properties of these 
complexes.163 In both cases, the addition of the neutral ligand yields an UV−vis spectrum 
with properties similar to those of the spectrum of the ferrous Δ276 DGCR8 protein, 
suggesting that, in the ferrous state, DGCR8 is coordinated by neutral axial ligand or 
ligands, prospectively through CysH/CysH coordination. 
 
Again the ferrous CO complex have a soret feature at 420nm, which is generally 
considered to be the species  arising from protonation of proximal thiolate ligand to the 
thiol form. However, the histidine ligated heme protein also have a similar spectrum in 
their ferrous CO form. Thus, the absence of a Soret band at 450 nm thus strongly 
suggests that in its ferrous, CO-bound state the DGCR8 heme iron is not coordinated to 
the protein by a thiolate ligand but instead via a neutral thiol or a histidine. 
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Figure A2 Uv-vis spectra of DGCR8. Ferric DGCR8 is in red, ferrous form is in green 
while the Ferrous-CO complex form is in Blue.  
3. Resonance Raman spectroscopic analysis of DGCR8.  
A. Preparation of samples for resonance Raman measurements. 
The concentration of ferric DGCR8 sample was 85 M in 50 mM Tris (pH=8.0), 
500 mM KCl containing 10% glycerol. The 50 μL ferric sample was transferred into an 
NMR tube for measurements. The ferrous form of the protein, dissolved in the glycerol 
containing buffer, was then generated by first degassing the DGCR8 sample under 
oxygen-free nitrogen, before adding a 20-fold molar excess of sodium dithionite and the 
redox mediators methyl viologen (MV) and benzyl viologen (BV) to final concentrations 
of 0.3 M and 1 M, respectively, these additives being dissolved in the same glycerol 
containing buffer. Reduction of the hemoprotein was monitored by electronic absorption 
133 
 
spectrophotometry in the UV-visible region, noting that full reduction required up to one 
hour. The ferrous-CO complex was then prepared by saturation of a sample of DGCR8 
with CO prior to the addition of sodium dithionite and the BV and MV mediators (as was 
done for the ferrous, CO-free sample). Formation of the DGCR8 ferrous-CO complex 
was monitored by observation of the electronic absorption spectrum to ensure complete 
formation of the CO complex.  
It is noted that a second sample of the ferric enzyme was prepared in glycerol-free 
buffer and studied in an effort to resolve an apparent conflict with previous reports 
regarding spin state populations (vide infra).36 This second sample was prepared in the 
same buffer, but lacking glycerol, by adding 50 µL of the glycerol free buffer (50 mM 
Tris (pH=8.0), 500 mM KCl) to 50 µL of the sample in the original (with 10% glycerol) 
buffer contained in a centrifugal filter cartridge (10K molecular weight cut-off) and 
concentrating the 100 µL resulting solution to 50 µL using a microcentrifuge at 8000 rpm 
at 4 °C. This process was repeated 8 times to ensure the buffer was completely 
exchanged.  
B. Resonance Raman Measurements. 
The ferric DGCR8 sample was measured with the  441.6 nm excitation line from 
a He-Cd laser (IK Series He−Cd laser, Kimmon Koha CO., Ltd.), while the ferrous 
DGCR8 sample was measured with the 415 nm line provided by a Kr+ laser (Coherent 
Innova Sabre Ion Laser). The spectra of the Fe(II)-CO adducts were acquired with the 
441.6 nm line. The RR spectra of all samples were measured using a Spex 1269 
spectrometer equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton 
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Instruments, NJ). The slit width was 150 μm, and the laser power was adjusted to ∼30 
mW at the laser for the ferric and ferrous samples, while the power of ~1 mW was 
maintained for the CO adducts to minimize photo dissociation. All samples were 
measured in a spinning NMR tube to avoid local heating and protein degradation. The 
spectra were collected using a 180° backscattering geometry, and the laser power was 
focused on the sample with a line image using a cylindrical lens. Spectra were calibrated 
with data acquired for fenchone and processed with Grams/32 AI software (Galactic 
Industries, Salem, NH). Data were collected at 4 (± 2) °C by placing the samples in a 
homemade quartz Dewar flask filled with cold water and monitoring during the 
measurements using a thermocouple.  
C. Results for ferric DGCR8 
The high frequency region of ferric DGCR8 sample is presented in Figure A3 (A). 
The region includes the oxidation state and spin state markers. As shown in Figure A3 
(A), the high frequency spectrum of the DGCR8 sample exhibits the oxidation state 
marker mode, ν4, at  1375 cm-1 and the ν3 spin-state marker at 1506 cm-1, confirming the 
presence of a ferric 6-coordinate low-spin state, in agreement with results from other 
methods used in this work. While there are some small differences (3-6 cm-1) in 
frequencies between our results and those reported in the earlier published data from Barr 
et al,164 they can be atributed to the one-point spectral calibration method used in the 
published work compared to the multipoint calibration used in the present studies; slight 
differences in relative intensities of bands between the two works are attributable to the 
fact that two different excittaions lines were used (441.6 vs 457.9 nm). A more 
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worrisome discrepancy is the fact that a weak 1471 cm-1 band  seen in the earlier work 
was taken as evidence for a 5-coordinate high spin component. Indeed, in the present 
work a band is also observed in Figure A3 near this frequency (1465 cm-1), but is 
assigned to an internal mode of glycerol, whose concentration is 10% (volume/volume) 
in our sample; it is noted that samples studied in the published report also contained 10% 
glycerol. In order to verify the assignment of this 1465cm-1 feature to glycerol, further 
experiments were conducted on a DGCR8 sample containing no glycerol. The inset in 
Figure A3 (A) shows spectra of the ferric DGCR8 sample containing 10% glycerol buffer 
(a), a sample in the same buffer without glycerol (b) and their difference spectrum (c). In 
the difference spectrum, all the heme modes were cleanly cancelled out, revealing only 
the 1465 cm-1 glycerol band. Thus, we assigned this band to the 10% glycerol present in 
the original protein solution, confirming the interpretation that the ferric protein samples 
studied here contain an insignificant amount of 5-coordinate HS state. The low frequency 
region of the RR spectrum is shown in Figure A4 (A) which is as the supporting 
information attached in published article.  
D. Results for ferrous DGCR8 
In the ferrous state, the high-frequency region (Figure A3 B) exhibited the 
oxidation state marker band (4) at 1362 cm-1 and the spin-state marker band (3) at 1495 
cm-1, indicating a low-spin 6-coordinated ferrous heme protein. Again, the weak broad 
glycerol band near 1465 cm-1 was observed. In the earlier work, a 1470 cm-1 band was 
observed and assigned to the ν3 mode of a 5-coordinate HS component, again prompting 
the conclusion of a mixture of 5- and 6-coordinate forms of the ferrous protein, as was 
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reported in that work for the ferric state.164 While that 1470 cm-1 feature is reasonably 
close to the expected glycerol band, the frequency observed is slightly higher than 
expected. Considering it not to be a mis-calibrated glycerol band, the authors assigned it 
to the ν3 mode of a HS component, also assigning a feature at 1579 cm-1 to the ν2 mode of 
that HS component; however, this frequency is unusually high for a HS component. 
Acceptance of the 1470 cm-1 feature observed in the earlier work as confirmation of a HS 
component suggests that the sample studied there (the frog 278-498) does form a HS 
component, while the isoform of interest in this work (human 276-773) does not form a 
HS species, under the conditions studied here. The low-frequency rR spectrum of ferrous 
DGCR8 is shown in Figure A4 B.  
E. Results for ferrous CO complex of DGCR8 
As was pointed out above, the appearance of a Soret band near 420 nm for the 
ferrous CO adduct of DGCR8 is indicative of a 6-coordinate CO ligated heme bearing a 
neutral (e.g., thiol or histidine) trans-axial ligand. Resonance Raman spectra in the region 
between 1000-1650 cm-1, provided in Figure A4 (C) of Supporting Information, reveal 
the oxidation state marker band (4) at 1373 cm-1 and spin state marker band (3) at 1497 
cm-1, consistent with values typically seen for these low spin CO adducts of cytochromes 
P450.59, 69 The regions of the RR spectra of the Fe-CO and Fe-13CO adducts of the 
DGCR8, wherein the ν(Fe-C) and ν(C-O) stretching modes occur, are shown in Figure 
A3 (C). In the lower frequency region a clean difference pattern emerges from a ν(Fe-
12C) mode appearing at 496 cm-1, with its 13C counterpart shifting to 490 cm-1. The 
corresponding ν(C-O) bands appear at 1963 cm-1 for 12C-O and at 1917 cm-1 for the 13C 
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analogue. Finally, a clean difference pattern, with components at 575 and 557 cm-1, 
reveal the δ(Fe-C-O) bending mode. 
Figure A3 (D) shows the well-established inverse correlation plots for ν(Fe-C) vs 
ν(C-O) modes, which are useful for probing the nature of the distal heme pockets and 
proximal ligands.57  Thus, the lowest line in the figure includes data for the cytochromes 
P450, which possess the strongly electron donating thiolate proximal ligand, leading to 
relatively high ν(Fe-S) stretching modes occurring near 350-355 cm-1. Just above this line 
lies the correlation plot for NOS enzymes, which possess proximal pocket residues that 
provide H-bond donor fragments to the proximal thiolate ligand, weakening the Fe-S 
linkage; possessing lower ν(Fe-S) frequencies (337-343 cm-1), these show 
correspondingly higher ν(Fe-C) stretching modes. Highest in the figure is the correlation 
line for histidine bound Fe-CO complexes. As was discussed above, actual protonation of 
the trans-axial thiolate  to form a trans thiol-ligated species,  as has been suggested for 
cytochromes P420,165  would lead to an even weaker Fe-S bond and higher ν(Fe-C) 
stretching frequencies, compared to those seen for NOS adducts. Indeed, the points 
acquired for the P420 forms of iNOS and for CYP101,127 as well as one for a well-
characterized CO adduct of a heme model compound bearing a trans-axial thiol,166 lie 
near the line corresponding to histidine ligated CO adducts.  
It is interesting to note that these rR results described above for the ferrous CO 
adduct provide useful insight regarding the coordination status of the ferrous form. Thus, 
in the case of the ferrous heme adopting a thiol/thiolate coordination, where it is 
reasonably expected that the Fe-thiolate bond is stronger than the Fe-thiol bond, a CO 
complex of heme bearing a trans thiolate ligand would likely be formed, for which the 
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correlation point would fall near the line corresponding to cytochromes P450. However, 
the point determined herein for the CO adduct of DGCR8 clearly lies in the 
neighbourhood of these adducts bearing a trans-axial thiol ligand; i.e., near the line 
corresponding to histidine-ligated CO adducts. Thus, the rR data obtained here for the 
ferrous DGCR8 CO complex supports the conclusion that the ferrous form of this 
enzyme possesses a thiol/thiol coordination environment, rather than a thiol/thiolate 
formulation. 
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Figure A3 A) the high-frequency RR spectra for the ferric DGCR8 aquired with 442 nm 
laser lines. (85 M ferric DGCR8, in TRIS pH 8.0, 500mM KCl, 10% glycerol). The 
inset shows the ferric DGCR8 in 10% glycerol buffer (a), ferric DGCR8 in same buffer 
without glycerol (b) and their difference traces (c); B) The high-frequency RR spectra for 
the ferrous DGCR8 acquired with the 415 nm laser line (85 M DGCR8 reduced under 
inert atmosphere of N2 with 20 time molar excess of sodium dithionate in the presence of 
methyl viologen and benzyl viologen); C) The low-frequency (left-panel) and high-
frequency (right panel) RR spectral region of ferrous adducts of DGCR8. The middle 
trace in each panel shows 12C16O – 13C16O difference plot in the (Fe-C) and  (C-O) regions 
(respectively in the left and right panels); D) The CO-backbonding correlation lines of 
P450 cam (L= thiolate), histidine ligated enzymes (L=his) and NOS (L- thiolate).140 Data 
points (•) associated with heme- thiol model complex, DGCR8, iNOS P420 and iNOS 
P450.166  
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Figure A4 A) The low-frequency RR spectra for the ferric DGCR8 acquired with 442nm 
laser line. Experimental conditions same as in Figure A1 for the corresponding high-
frequency regions; B) the low-frequency RR spectra for the ferrous DGCR8 acquired 
with the 415 nm laser line. Experimental condition as in Figure 3C; C) The low-
frequency RR spectra of the carbon monoxide and its 13CO isotopomer complex of 
DGCR8 acquired with the 415 nm laser line; D) The high-frequency RR spectra of the 
carbon monoxide and its 13CO isotopomer complex of DGCR8 acquired with the 415 nm 
laser line. 
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